(310 ITEMS) - Gujarat State Portal · 5 of 51 73 1208 Misoprostol Tab. 200 mcg. 106300 74 1213 Paracetamol Kid Tablets 125mg 175300 75 1214 Aceclofenac Tablets100 Mg 436100

1 of 51

TENDER DOCUMENT

FOR

TABLET,CAPSULES,

INJECTION,MISCELLANEOUS,

&

SURGICAL ITEMS

(310 ITEMS)

T.E.NO.GMSCL/D-629/RC/2018-19

Gujarat Medical Service Corporation

Limited

(A government of Gujarat Undertaking)

2 of 51

Index

SR.

NO

CONTENTS PAGE

A. GENERAL INSTRUCTIONS FOR BIDDERS 12

B ELIGIBILITY CRITERIA 13

C TECHNICAL BID 15

D GENERAL TERMS AND CONDITIONS OF TENDER 16

E COMMERCIAL BID 20

F OPENING OF TECHNICAL AND COMMERCIAL BID 20

G ACCEPTANCE OF BID 21

H SECURITY DEPOSIT 21

I AGREEMENT 22

J SUPPLY CONDITIONS 22

K SHELF LIFE 24

L PACKING AND LOGOGRAM 25

M QUALITY TESTING 28

N PAYMENT PROVISION 29

O FALL CLAUSE 31

P STANDARD BREACH CLAUSES 31

Q INSPECTION 32

R WARRANTY CLAUSE 32

S JURISDICTION 32

ANNEXURE- I 33

ANNEXURE-II 34

ANNEXURE-III 35

ANNEXURE-IV 36

ANNEXURE-V 38

ANNEXURE-VI 39

ANNEXURE-VII 40

ANNEXURE-VIII 41

ANNEXURE-IX 42

ANNEXURE –X 43 to 45

ANNEXURE-XI 46

ANNEXURE-XII 47

ANNEXURE-XIII 48

BIDDING SCHEDULE 50 to 51

3 of 51

Tender Notice

Tender Notice No.: GMSCL/ D-15 /2018-2019

Tender Brief

Tenders are invited online (through internet) from reputed manufacturers / direct importers for

supply of following drug items for period of two years on Rate contract basis as mentioned in

the tender details section.

Tender Details

GUJARAT MEDICAL SERVICES CORPORATION LIMITED

Block No.14/1, Dr. Jivraj Mehta Bhavan, Sector-10,

Gandhinagar.℡ 23250766 / 67 / 70

TENDER NOTICE: D-15/2018-2019 Tenders are invited online (through internet) from reputed Manufacturers / Direct importers for purchase of following items on rate contract basis. All tender documents canbe downloaded free from web site http://gmscl.nprocure.com between 17/04/2018 to 07/05/2018 up to15.55 Hrs

TENDER ENQUIRY NO-GMSCL/D-629/RC/2018-19(ON RATECONTRACT BASIS)

TENDER ENQUIRY NO-GMSCL/D-629/RC/2018-19(ON RATE CONTRACT BASIS)

ITEM: : Tablet ,Capsule ,Miscellaneous & surgical items

Document Fee: 15000/-

E.M.D. : Item wise EMD as shown below

Sr No.

Itemcode Name of Item EMD (Rs.)

1 1001 Acetazolamide Tablets 250 mg 28700

2 1005 Acyclovir Tablets 200mg 84400

3 1006 Albendazole Tablets400 mg 785700

4 1012 Amitriptyline HCL Tablets 25mg 50300

5 1013 Amlodipine Tablets 5mg 121400

6 1016 Amoxycillin Capsules 500 mg 5153900

7 1017 Amoxycillin Capsules 250 mg 1911800

8 1018 Amoxycillin Dispersible

Kid Tablets 125 mg 756000

9 1021 Ascorbic Acid Tablets 500mg 910800

10 1023 Atenolol Tablets 50 mg 417900

11 1025 Benzhexol Tablets (Trihexyphenidyl) 2mg 20000

12 1026 Bisacodyl Tablets 5mg 98100

13 1031 Carbamazepine Tablets 200 mg 288000

14 1034 Cefadroxil Kid Tablets 125mg 639400

15 1039 Chloroquine Tablets250 mg 646100

16 1040 Chloroquine Tablets 500mg. 20300

17 1041 Chlorpheniramine Maleate Tablets 4mg 615500

18 1051 Clotrimazole Vaginal Tablets 100 mg 151800

19 1059 Dexamethasone Tablets 0.5 mg 193000

20 1060 Diazepam Tablets 5 mg 32600

21 1061 Diclofenac Sodium Tablets 50mg 1427600

22 1062 Dicyclomine Tablets 20mg 209000

23 1063 Diethylcarbamazine CitrateTablets 100 mg 7500

24 1064 Digoxin Tablets 0.25 mg 23300

http://gmscl.nprocure.com/

4 of 51

25 1065 Diloxanide Furoate Tablets 500mg 25000

26 1068 Domperidone Tablets 10 mg 231900

27 1071 Doxycycline Capsules 100mg 851300

28 1072 Enalapril Tablets 5 mg 267700

29 1075 Eteophylline& Theophylline Tablets 444300

30 1081 Ferrous Sulphate Tablets 200mg 154300

31 1083 Fluoxetine Capsules 20 mg 73100

32 1084 Folic Acid & Ferrous Sulphate Tablets (Small) 154000

33 1086 Folic Acid Tablets 5mg 462000

34 1087 Frusemide Tablets 40mg 111400

35 1093 Haloperidol Tablets 5mg 5000

36 1096 Ibuprofen Tablets 400mg 1751400

37 1100 IsosorbideDinitrate Tablets 10mg 44000

38 1107 Mefloquine Tablet 250Mg 300

39 1108 Metformin Tablets 500 mg 1135300

40 1110 Methyldopa Tablets 250 mg 63700

41 1112 Metoclopramide Tablets 10mg 12500

42 1113 Metronidazole Tablets 400 mg 1859400

43 1114 Metronidazole Tablets 200mg 279400

44 1119 Norethisterone Tablets 5mg 42500

45 1120 Norfloxacin Kid Tablets 100mg 99400

46 1121 Norfloxacin Tablets 400 mg 1108100

47 1124 Ofloxacin Tablets 200mg 686000

48 1127 Paracetamol Tablets 500mg 4358000

49 1134 Prednisolone Tablets 5 mg 228500

50 1135 Primaquine Tablets 2.5 mg 14700

51 1148 Quinine Tablets 300 mg 12100

52 1149 Quinine Tablets 100 mg 5200

53 1152 Risperidone Tablets 2mg 59500

54 1154 Salbutamol Tablets 4mg 72800

55 1155 Sodium Valproate Tablets 200 mg 1034400

56 1156 Sodium Valproate Tablets 500 mg 249100

57 1158 Spironolactone Tablets 25 mg 261700

58 1167 TrifluoperazineHCL Tablets 5mg 18100

59 1168 Trimethoprim&Sulphamethoxazole Tab 480 mg 1403600

60 1171 Vitamin A Capsules 50,000 IU 105300

61 1172 Vitamin A Capsules 2,00,000 IU 198000

62 1173 Vitamin B Complex Tablets (Therapeutic) 2181100

63 1178 Fluconazole Tablets 50mg 92500

64 1182 Salbutamol Rotacaps 200mcg 32600

65 1185 Azithromycin Tablets 500 mg. 4958600

66 1198 Atorvastatine Tablets 10 mg 458600

67 1199 Cefixime Tablet 200mg 3848600

68 1200 Diclofenec Sodium Suppository 12.5mg. 27300

69 1202 EsCitalopram Oxalate Tablets 10 mg 56100

70 1203 Lorazepam Tablet 2mg 35800

71 1204 Metoprolol Tablets 25mg 120900

72 1205 Olanzapine Tablet 5mg 48500

5 of 51

73 1208 Misoprostol Tab. 200 mcg. 106300

74 1213 Paracetamol Kid Tablets 125mg 175300

75 1214 Aceclofenac Tablets100 Mg 436100

76 1218 Levofloxacin Tablets 500mg. 786500

77 1221 Losartan Potassium Tablets 50mg. 142800

78 1224 Pantoprazole Tablets 40mg. 1286800

79 1226 Glimepiride Tablets1mg. 103500

80 1230 Artemether & Lumefantrine Tablets 12100

81 1240 Spironolactone Tablets 100 mg 108200

82 1242 Clopidogrel Tablets 75 mg 158000

83 1243 Levothyroxine Tablets 50mcg 1000


85 1249 Tramadol Capsules 50 mg 82200

86 1250 Tramadol Capsules 100 mg 33600

87 1251 Zinc Sulphate Dispersible Tablets 20mg 116900

88 1253 Deferasirox Tablets 250 mg 277500

89 1254 Deferasirox Tablets 500mg 1137300

90 1257 Atorvastatin Tab. 40mg. 410500

91 1258 Bisacodyl Suppository 37600

92 1260 Diclofenac Sodium Suppository 50mg. 27600

93 1262 Ferrous Sulphate and Folic Acid Tablets 100 mg + 0.5 mg 1805300

94 1268 Oseltamivir Capsule 75 mg 2328100

95 1266 Acetyl Salicylic Acid Tablet 350 mg 10600

96 1269 Nifedipine Sustain Release Tab. 10mg 37700

97 1270 Carvedilol Tablet 12.5mg 32700

98 1271 Fluconazole Tablet 150 mg 670800

99 1272 Cefadroxil Tablet 500 mg 28427200

100 1273 Iron Folic Acid (IFA) Tablet (Small)pink 2145200

101 1276 Famotidine Tablets 40 mg 1099800

102 1277 Famotidine Tablets 20 mg 907000

103 1300 Clobazam Capsule 5mg 188200

104 1307 Kit3/ White Clr Benzathine Penicillin Inj & Azithromycin Tab 1000


106 1321 Tab. Aripiprazole 15 mg 20800

107 1326 Tab. Methyl Phenidate 10 mg 11100

108 1328 Tab. Atomoxetine 18 mg 13600

109 1336 Cap. Atazanavir 300mg 1000

110 1340 Tab. ZL Baby (Zidovudine 60mg + Lamivudine 30mg) 1000

111 1342 Tab. Nevirapine 50mg 1000

112 1343 Tab. Lopinavir 100mg & Ritonavir 25mg. 1000

113 1344 Abamune L Baby(Abacavir 60mg&Lamivudine 30mg) 1000

114 1352 Tab.Nitazoxanide 500 mg 1000


116 1358 Labetalol Tablet 50 mg 1000


118 2003 Amikacin Sulphate Injection(For IM/IV Use) 500mg 853400

119 2004 Amikacin Sulphate Injection(For IM/IV Use) 100mg 60100

120 2005 Aminophylline Injection(For IV Use) 2.5% w/v 18800

6 of 51

121 2007 Amoxycillin & Clavulanic Acid Injection 300mg 80200

122 2010 Ampicillin Sodium Injection 500mg(IM/slow IV use) 74000

123 2012 Anti-D (RHO) Immunoglobulin (Human) Injection 300mcg (liquid

Form) 1503400

124 2013 Artemether Injection 80 mg 11400

125 2014 AtracuriumBesilate Injection 10 mg/ml 139400

126 2015 Atropine Sulphate Inj. (1ml Ampoule) 74000

127 2019 Bupivacaine HCLInjecton (20ml Vial) 64000

128 2023 Cefazoline Sodium Injection 500 mg 31600

129 2027 Ceftazidime Injection 1 Gm 40300

130 2029 Ceftriaxone for Injection 500 mg 146800

131 2031 Chloroquine Phosphate Injection 40 mg/ml 18400

132 2032 Pheniramine Maleate Injection (For IM/IV Use) 123300

133 2039 Dexamethasone Sodium Injection 4 mg/ml 262800

134 2046 DiatrizoateMaglum.&Diat. Sod.Inj. 60% 13100

135 2047 DiatrizoateMaglum.&Diat. Sod.Inj. 76% 71300

136 2048 Diazepam Injection 5 mg/ml 62800

137 2049 Diclofenac Sodium Injection 25 mg/ml 423500

138 2050 Dicyclomine Injection 20 mg/2 ml 69300

139 2056 Dobutamine Injection 50 mg/ ml 81900

140 2057 Dopamine Injection 40 mg/ ml 76400

141 2059 Eteophylline & Theophylline Injection 153000

142 2061 Fentanyl Inj.50mcg/ml, 2ml Amp. 1000

143 2065 Frusemide Injection 10 mg/ml 90000

144 2073 Haloperidol Injection (For IM/IV Use) 4900

145 2074 Heparin Injection 5000 i.u./ml 429100

146 2075 Hepatitis B Vaccine 10mcg/0.5 ml (1ml Amp) 38900

147 2076 Hepatitis B Vaccine 10mcg/0.5ml (10ml Vial) 18600

148 2079 Hydrocortisone Sod.SuccinateInj 100mg 243400

149 2088 Ketamine Hydrochloride Injection 50 mg. (Deep IM/slow IV use) 105400

150 2090 Lignocaine & Adrenaline Injection 30 ml Vial 25900

151 2097 LyophilisedAntisnake Venom Serum (Powder) 2220000

152 2107 Inj. Mephenteramine 15 mg/ml Via 12100

153 2108 Methotrexate Injection 50 mg/2 ml 1000

154 2109 Methyl Ergometrine Maleate Inj 0.2 mg/ml 38400

155 2111 Metoclopramide Injection 5 mg/ml 10600

156 2117 Inj. Gas Gangrene Antitoxine 108000

157 2122 Neostigmine Inj 0.5 mg/ml (1ml Ampoule 53900

158 2128 Paracetamol Injection 150 mg/ml 277900

159 2129 Pentazocine Injection 30 mg/ml 77300

160 2135 Pralidoxime Chloride Injection 1Gm 331700

161 2138 Promethazine HCL Injection. 21100

162 2141 Quinine DihydrochlorideInj 300mg/ml 7800

163 2143 Ranitidine Injection 50 mg/2 ml 472000

164 2145 Sodium Bicarbonate Injection 7.5% w/v 29400

165 2151 Sterile Vancomycin Injection 0.5 gm 322000

166 2153 Sterile Water for Injection (5ml) 249300

167 2160 Immunoglob.T.T. Human Injection 250 IU 364500

7 of 51

168 2162 Tetanus Toxoid (Adsorbed) Injection 634000

169 2164 Thiopentone Injection 500 mg 41600

170 2168 Vecuronium Bromide Injection 4 mg/ml 83600

171 2173 Vitamin B Complex Injection (For IM Use) 72600

172 2186 Vecuronium Bromide Injection 4 mg/ml 293200

173 2190 Vitamin B12 Injection 61000

174 2195 Glycopyrrolate Injection (0.2mg/ml) 71700

175 2197 Iohexol Injection 300mg/ml (50ml vial) 130100

176 2198 Methyl Prednisolone Sod.Succ.Inj. 500mg 497600

177 2203 Sodium Chloride(Normal Saline) Inj 100 ml 801600

178 2213 Meropenem Injections 500mg 502200

179 2214 Levofloxacin Injections (500mg./100ml) 207400

180 2215 Aciclovir Injections 250mg. (Dry Powder) 73400

181 2217 Fat Emulsion Injections 20% w/v (PL/TG Ratio 0.06) 250ml 79200

182 2219 Amino Acid 10% Injection 248500

183 2227 Enoxaparin Sodium

Injection 60mg/0.6ml 682400

184 2228 Iron & Sucrose Inj.5ml/Amp. 875200

185 2229 Sulbactum & Cefoperazone for Injection 1gm 529600

186 2242 Tramadol Injection 50 mg / ml 116800

187 2248 Atropine Sulphate Injection 0.6mg/ml, 30ml Vial 55700

188 2250 Cisplatin Injection 10 mg (Intravenous Infusion) 5900

189 2251 Cisplatin Injection 50 mg(Intravenous Infusion) 73700

190 2254 Hydroxyethyl Starch 6% w/v (Intravenous Infusion) 107400

191 2255 Phytomenadione (Vit.K1) Inj. (1mg/1ml) 199000

192 2258 Bupivacaine Hydrochloride in Dextrose Injection 5mg + 80mg per

ml 50000

193 2271 Filgrastim 300mcg Injection 35500

194 2275 Inj. Valethamate Bromide 23900

195 2290 Inj Lorazepam 2ml 9700

196 2291 Olanzapine Inj. (for IM use) 1000

197 2292 Inj Flupenthixol Depot 2ml 56200

198 2293 Inj Clopixol depot 20mg(Zuclopenthixol injection) 38400

199 2294 Deferoxamine mesylate inj 500 mg 729300

200 2300 Ulinastatin for injection 1,00,000 IU 342000

201 2303 Nadroparin Injection 0.6 ml 45000

202 2310 Inj Ganciclovir 600 mg 1000

203 2311 Sodium Chloride (Normal Saline) Inj 1000 ml. 1000

204 2312 Cyclophosphamide injection 1 GM 1000

205 2313 Fluro-Uracil Injection 500 mg/10 ml. 1000

206 2314 Inj Balance salt solution(Glass bottle) 500 ml 1000

207 3002 Albendazole Suspension 200 mg/5 ml 10 ml Bottle 277800

208 3013 HbsAg-Rapid Test Kit(Australia Antigen Kit) (RPHA) 213200

209 3015 Betamethasone Cream 0.05% 903000

210 3024 Chloroquine Phosphate Syrup 100 mg/10ml 64200

211 3026 Cholecalciferol Granules (Vitamin D3) 198000

212 3028 Clotrimazole Cream 1% 941900

213 3029 Compound Benzoic Acid Ointment (Whitefield's oint.) 635000

214 3030 Vitamin A Solution Conc.1 Lac IU/1ml 591500

8 of 51

215 3033 Dextromethorphan Syrup 13.5 mg/ 5 ml 1832800

216 3037 DicyclomineHCL Oral Solution 10 mg/5ml 172600

217 3065 Halothane Liquid 250ml Bottle 69000

218 3068 Hydrogen Peroxide Solution 200 ml Bottle 74800

219 3070 Ibuprofen Suspension 100 mg/5 ml 269800

220 3073 Isoflurane Liquid (100 ml) 43200

221 3088 Paracetamol Syrup 125 mg/5 ml 1179200

222 3090 Petroleum Jelly (White) 296900

223 3100 Povidone Iodine Solution 5% 1 Litre Jar 355000

224 3105 Salbutamol Syrup 2 mg/5 ml 100ml Bottle 522300

225 3106 Sevoflurane Liquid 250 ml Bottle 1389500

226 3107 Silver Sulphadiazine Cream 1% 500 gm Jar 616500

227 3109 Sodium Hypochlorite Solution 5 Liter Jar 1000

228 3111 Strips for esti.ofAlbu& Glu.in Urine 1000

229 3114 Timolol Maleate Eye Drops 0.25% 13400

230 3117 Trimethoprim &SulphamethoxazoleSusp. 614200

231 3131 Calamine Lotion 279700

232 3138 HCV Elisa Test Kit (upto 96 Test) 178700

233 3139 HCV Rapid Test Kit (upto 100Test) 202700

234 3142 Povidone Iodine Ointment 5% (20gm Tube) 775800

235 3143 Pregnancy Test Kit (upto 50 Test) 333400

236 3157 Serum VDRL Test Kit (100 Tests) 66300

237 3158 Serum Widal Estimation Kit (4x5ml) 20400

238 3159 Silver Sulphadiazine Cream 1% (20gm tube) 314200

239 3162 Azithromycin Oral Suspension 200mg/5ml 516700

240 3168 Diazepam Rectal Solution 2mg/ml 1000

241 3175 Compound Benzoin Tincture 500 ml Bottle 78200

242 3183 Clobetasol Propionate Cream 614500

243 3200 Levocetirizine Dihydrochloride Syrup 30 ml Bottle 667800

244 3202 Permethrin Cream 5% 30gm. tube 82800

245 3203 Lactulose Solution 100 ml Bottle 334100

246 3207 Cephalexin Syrup 125 mg / 5 m 358900

247 3209 Glycerine 100 ml Bottle 91500

248 3211 Magnesium Sulphate Powde 5900

249 3214 Petroleum Jelly (White) 30 gm Tube 367900

250 3216 Zinc Gluconate Syrup 20 mg / ml 301200

251 3224 Cyclopentolate Eye Drop 5ml 21000

252 3225 Lignocaine HCL Jelly 5%, 30gm Tube 211500

253 3227 Moxifloxacine Eye Drop 5ml 961700

254 3230 Prednisolone Acetate Eye Drop 0.1%, 5ml 1000

255 3231 Tobramycine Eye Drop 03% w/v 10ml 1000

256 3232 Iron Folic Acid (IFA) Syrup 457600

257 3234 Dianoprostone Gel 3%, 3gm. Tube 537400

258 3236 Clotrimazole with Beclomethasone Drops 1% 256400

259 3237 Neomycin, Hydrocortisone &Polymixin B Ear Drops 418300

260 3238 Brimonidine Tartrate and Timolol Eye Drops 0.15% + 0.5% 91800

261 3240 Tobramycin and Dexamethasone Ophthalmic Suspension

0.30%+0.10% 16700

9 of 51

262 3244 Hydroxyproply Methylcellulose Soln. 108500

263 3245 Neomycin Sulphate, Polymyxine B Sulphate, Bacitracon Zinc

Powder 10gm 421200

264 3246 Artemether&Lumifantrine Pediatric Syrup 15 m 700

265 3315 Syrup Lopinavir + Ritonavir (80/20mg./ml) 160ml per bottle 1000

266 4004 Adhesive Zinc Tape 5cmx10mtr 474000

267 4005 Adhesive Zinc Tape 7.5cmx10mtr 358200

268 4007 Blood Administration Set (ETO) 82200

269 4009 Crepe Bandage Pack (10cmx4mtr) 354000

270 4010 Crepe Bandage Pack (6cmx4mtr) 105500

271 4011 Disposable Hypodermic Needle Size:22x1" 265700



274 4017 Infusion Set (E.T.O.Sterilised) 2506000

275 4019 Disposable Syringe 10 ml (Without Needle) 1292100



278 4022 Plaster Of Paris Bandage (10cm x 2.7mtr) 239000

279 4023 Plaster Of Paris Bandage (15cm x 2.7mtr) 389700

280 4024 Rolled Bandage (5mt x 5cm) 703200

281 4028 Ab.Surg.Sut.Catgut Plain 2-0 w/o needle 23200

282 4035 Ab.Surg.Sut.Catgut Chromic 1 w/o needle 12800

283 4036 Ab.Surg.Sut.Catgut Chromic 2-0 w/o needle 5000

284 4038 Ab.Surg.Sut.Catgut Chromic 2-0 w/o needle 10300

285 4045 Ab.Sur.Sut.Chromic 2-0 with 1/2Cir.RB30m 47300

286 4047 Ab.Sur.Sut.Chromic 3-0 with 1/2Cir.RB20m 8300

287 4063 Ab.Sur.Sut.Polygly.3-0 with1/2Cir.RB17mm 12200

288 4090 Non-abs.BB.Silksut.on Reel 1 (25mtr) 41900

289 4120 Non-ab. Monofi.Polyamid 3-0 3/8circut16mm 32800

290 4121 Non-ab.Monofi.Polyamid 4-0 3/8circut16mm 14000

291 4179 Absorbent Cotton Wool 400gm 1677000

292 4182 Disposable Needle Size: 26x0.5" 11500

293 4184 Insulin Syringe with Needle) 1ml 40 units 205500

294 4187 I.V Cannula Size 16 G 6700

295 4188 I.V Cannula Size 18 G 126100

296 4189 I.V Cannula Size 20 G 383600

297 4190 I.V Cannula Size 22 G 448700

298 4191 I.V Cannula Size 24 G 345200

299 4198 Elastic Adhesive Bandage Size:10cmX2.70Mtr 617800

300 4227 Foley's Catheter 8 FR (3 to 5 CC Balloon) (Paed) 38700

301 4228 Foley's Catheter 10 FR (3 to 5 CC Balloon) (Paed) 29500

302 4229 Foley's Catheter 12 FR(30 to 50 CC Balloon) 36800

303 4230 Foley's Cath. 14 FR (30 to 50CC Balloon) (2 Way) 125500

304 4231 Foley's Cath. 16 FR (30 to 50CC Balloon) (2 Way) 223100

305 4232 Foley's Cath. 18FR (30 to 50CC Balloon) (2 Way) 79300

306 4269 Disposable Syringe 20 ml 86500

307 4270 Disposable Syringe 50 ml 116300

308 4275 Disposable Spinal Needle (Size: 22G) 8200

10 of 51

309 4278 Disposable Spinal Needle (Size: 23G) 152000

310 4305 Micropore Adhesive paper Tape 71800

Note: For detailed specification refer to Schedule to STANDARD, COMPOSITION,

PACKING ,EMD, MINIMUM BATCH SIZE, WHO GMP, PACKING PER CARTON,

APPROX TWO YEARS REQUIREMENT.

11 of 51

Instruction to Bidders for Online Tender Participation

1-All tender documents can be downloaded free from the website https://gmscl.nprocure.com

2-All bids should be submitted online from the website https://gmscl.nprocure.com

3-All bids should be digitally signed, for details regarding digital signature certificate and related

training involved the below mentioned address should be contacted

(n) Code solutions (A divisionof GNFC) 301, GNFC Infotower, Bodakdev,Ahmedabad

Ahmedabad-380 054 ( India ) Tel : +91 79 26857316/17/18

Fax: +91 79 26857321. www.ncodesolutions.com

4-The user can get a copy of instructions to online participation from the website

https://gmscl.nprocure.com.

5. The suppliers should register on the website though the “New Supplier” link provided at the

home page the registration on the site should not be taken as registration or empanelment

or any other form ofregistration with the tendering authority.

6-The application for training and issue of digital signature certificates should be made at least 72 hours in advance to the due date and time of tender submission.

7-For all queries regarding use of digital signature certificate should be addressed to personnel in M/s (n) Code Solutions.

(8).A-Group documents should be submitted online only and B-Group documents should

be submitted physical only as per Annexure-X.

8-For all queries regarding tender specifications and any other clauses included in tender document should be addressed to personnel in tendering office address provided below

Contact Details: Managing Director

Gujarat Medical Services Corporation Limited Regd. Office: Block No.14/1, Dr. Jivraj Mehta Bhavan, Sector-10, Gandhinagar. Tel: 079-23250770, 23250766 ,Fax: 079-23257586

Key Dates: Due Date and Time of Submission of

TechnicalBid&Commercial Bid. (online)

: 07 /05 /2018 Up to 16.00 Hrs.

Due Date and Time of PhysicalSubmission of

TechnicalSupporting Documents inclusive of Document

Fee& EMD

: 08 / 05 /2018 Up to 16.00 Hrs.

Due Date and Time of TechnicalBidOpening (online) : 09 /05 /2018 At 15.00 Hrs.

Envelopes containing the “Technical Supporting Documents”, inclusive of the “Document Fee”,

“EMD Fee” tobe submitted at the below mentioned address. Venue: Managing Director

Gujarat Medical Services Corporation Limited Regd. Office: Block No.14/1, Dr. Jivraj Mehta Bhavan, Sector-10, Gandhinagar. Tel: 079-23250770, 23250766 Fax: 079-23257586Key Value: Document Fee: -

EMD:-

http://www.ncodesolutions.com/

https://gmscl.nprocure.com/

12 of 51

A. GENERAL INSTRUCTIONS FOR BIDDERS

The bidders are instructed to read the complete bid document carefully. The following points

may be noted so that mistakes/lapses/shortcomings during Bid submission may be avoided.

1. It is expected from all bidders that they will ensure that documents to be used in bid set will be

given to a reliable person only. So that the confidentiality of your bid/ rates is maintained up to

bid opening & that your documents are not put to any misuse.

2. Complaints lodged in GMSCL should bear signature, name, Id proof and mobile number

of the complainant. This is important to avoid unauthenticated complaints or any persons who

have fraudulently made use of their letter heads. Therefore, unauthenticated complaints may

not be acted upon.

3. In case you are given any assurance of any favour in GMSCL, by anybody or if you are

directly or indirectly threatened or i n t i m i d a t e d of harming your bidding & subsequent

work in GMSCL, please inform immediately about the same to MD, GMSCL. It would be

better if evidence of such unfair activity of such person is produced so that action can be taken

against such person / institution and their details can be put on the website.

4. It is advisable for you to authorize only those persons for GMSCL tender who are

employed in your company on salary basis.

5. If any firm, etc. intends to lodge a complaint against a bidder with regard to bid (bid

Condition), it may do so within 21 days of opening of technical bid, in the office of GMSCL.

After the stipulated period, it will not be possible to act upon the complaint.

6. The turnover should be as per bid conditions. Do not submit Bid if the turnover of the firm is

less.

7. Quote only for the products for which your Product Permission meets the Bid specifications.

Do not quote if it differs with regard to any parameter.

8. Quote rate exactly as per packing unit of tender schedule. For example if the packing is

given for 10x10 tablets, the rate should be quoted for 10x10 tablets, and not for 1 tablet or

10 tablets.

9. Highlight the quoted items in the documents like Product Permission and Market

Standing Certificate, and also mark the item code no. at appropriate place in the documents.

10. The submitted product permission and other documents should be authentic. Date of issue of

the documents should be clearly visible.

12. In case there is any suggestion regarding Bid conditions/ specifications/ shelf life, strength,

packing/turn over etc. The suggestions should be submitted/sent/e – Mailed two/three days

earlier from the date of pre bid meeting so that the representation of the bidders may be well

processed and decision could be taken well in time.

13. No tender will be accepted after prescribed closing time for submission of the same. The

delay will not be condoned for any reason whatsoever including postal/transit delay. However,

if the last date of submission of tenders is declared as a holiday by the Government, the last

date of submission of tenders will be extended to the next working day.

14. The tenderer should confirm that the detailed specifications i.e. standard, composition, packing,

minimum batch size, WHOGMP of the items offered are strictly in accordance with the

specifications shown in the Schedule (Schedule of tender). The tenderer must also mention

the name of manufacturer in case of direct importers in Technical & Commercial. The

tenderer should also note the terms & conditions particularly those relating to the delivery

period, E.M.D., Marketing Data & Proof of Manufacturing Experience, Minimum batch size,

Payment terms, Penalty, Pre-dispatch sample testing, Rate Contract, replacement and Risk

purchase in which no relaxation will be given.

13 of 51

15. The tenders will be opened on the date, time & venue specified in tender notice and the

tenderer or his authorized agent has the liberty to be present at that time. However, in

unavoidable circumstances, the Managing Director can change the date / time / venue of

opening or open the tenders in the absence of tenderers or his agent at his discretion. In

case the specified date is declared as holiday by the Government, the tenders will be opened on

the next working day at the same time and venue specified in the tender.

16. If there is any query regarding Terms and condition in Bid document, you may contact

General Manager (LPQC), GMSCL

DGM(Drug Procurement), GMSCL

Manager (Drug Procurement), GMSCL

17. If any tenderer wishes to lodge any complaint against the other tenderer regarding submission

of false documents, information etc., The tenderer has to submit the complaint before price bid

opening along with deposit of Rs. 1,00,000 (Rupees One Lac only). The amount so deposited

shall be refunded if after scrutiny the complaint is found to be true by the Managing Director.

However, if the complaint is found to be false and malafide the deposit will be forfeited. No

interest shall be paid against this deposit. Any complaint received after price bid opening will

not be entertained. The facts relating to all such complaints as well as action taken thereof have

to be produced before the respective purchase committee for its consideration.

B. ELIGIBILITY CRITERIA

1. Bidder shall be a manufacturer having valid manufacturing license or direct importer

holding valid import license. Distributors/ Suppliers / Agents are not eligible to participate in

the Bids.

2. If manufacturer is not available for imported Drugs/ Surgicals /Diagnostic Kit, then

authorized representative or dealer shall be allowed to quote the tender. But such authorized

representative or dealer should be regular supplier of quoted product of that manufacturer for

preceding two years from the date of opening of technical bid and authority letter (As per

format Annexure VIII) & valid import license (where ever applicable) should be submitted

along with tender.

3. Must have minimum three years of experience as a manufacturer and in marketing of the quoted

item, as on the date of technical bid opening. The Bidder Should also have manufactured at

least 3 three commertial batches of the quoted drug every year in the last 3 consecutive years

(Annexure II). In case of imported product, the product should have minimum 3 years standing

in the market. The importer should have at least 3 years standing as manufacturer/ importer of

drugs in general. Imported drugs shall be accepted in brand name also.

4. (a)The Average Annual turnover of last three years should not be less than 2

crores.

(b) For SSI units of Gujarat the average annual turnover should not be less than Rs.75.00

lacs for list of items attached at annexure.( Annexure-XIII)

c)The Manufacturer should have valid WHOGMP Certificate or valid Certificate of

pharmaceutical product (COPP) for individual product in the WHO format. Unless the date of

expiry is specially mentioned in the certificate,the validity of WHOGMP (COPP) certificate will

be considered as two years from the date of issue, effect for foreign product where the tenders

most affirm the date of validity. No offer will be acceptable unless the tender is accompanied by

requisite WHOGMP describe above.Manufacturers not having valid WHOGMP certificate are

not entitled to submit tender.Under no circumstances submission of copies of renewal

application / challan for expired WHOGMP certificate will be considered in lieu of valid

WHOGMP certificate. Conditional WHOGMP will not be accepted..

(d) The Certificate mentioned above must include either the name of drugs or the category of

drugs for which the WHOGMP is issued. In case of imported Drugs/Surgicals/DiagnosticKit,

14 of 51

valid Drug ManufacturingLicense, ProductPermission, WHOGMP certificate of manufacturer,

Labels and Product literature of all quoted product must be submitted along with the tender.

5. In case, where the item is required with ISI Mark, manufacturing and selling experience of

product having ISI Mark is mandatory for eligibility. Hence the manufacturer must have valid

certificate copies of license to use ISI for last one year and the latest license should be valid

during the period of Rate Contact.

6. The SSI must have , a valid Micro/ Small enterprise registration ( As per Gazette of India Act-

2006) issued by concerned authority of Gujarat state along with valid certificate of CSPO/

NSIC/DGS & D/ KVIC Registration.

7. Bid should not be submitted for the product/products for which the

concern/company stands blacklisted/banned/debarred either by Bid inviting Authority or Govt.

of Gujarat or its departments on any ground. The Bid should not be submitted for those

products also for which the concern/company stands blacklisted/banned/debarred by any other

State/Central Govt. or it‟s any agencies (central Drugs procurement agencies) on the ground of

conviction by court of law or the products being found spurious or adulterated.

8. Such concern/company/firm which stand blacklisted/banned/debarred on any ground by the bid

inviting authority (GMSCL) or Govt. of Gujarat or its department on the date of bid submission,

shall not be eligible to participate in the bid. The concern/company/firm

which stands blacklisted/banned/debarred on the ground of conviction by court of law or the

products being found spurious or adulterated by any other State /Central Government or it‟s any

agencies (central Drugs procurement agencies) shall also not be eligible to participate in the

Bid. For Specific cases regarding other quality issues the respective purchase committee of

GMSCL may decide on case to case basis.

The concerned company/firm/bidder who has been blacklisted / debarred by GMSCL or any

other State/ Central Government and its Drug Procurement Agencies due to failure in supply

of Quality drugs, shall not participate in the tender during the period of debarring / blacklisting.

If any product of company/firm/bidder were blacklisted/debarred at the time of bidding, for a

specified period, then the same will become eligible after blacklisting/ debarring period is over.

In case the period is not specified the debarment order, the firm shall be eligible to participate

in bidding only after two years of the date of issue of the order of blacklisting/ debarment. If

any tenderer is debarred or black listed due to failure in supply of Quality Drug during the

tender validity or during the validity of the rate contract by any other State and central

Government and its Drug Procurement Agencies, it is his (tenderer‟s) responsibility to inform

such thing to the Managing Director, GMSCL.

9. Non-Disclosure of blacklisting/ debarment will invite forfeiture/recovery of EMD or SD or

Risk Purchase or disqualification for appropriate period or any other penal action at the

discretion of Managing Director, GMSCL without any further reference. (As per format

Annexure-IX)

10. The concern/firm/company whose product has been declared as of spurious or adulterated

quality and any criminal case is filed and pending in any court shall not be eligible to

participate for that particular product, in the Bid. Similarly convicted firm/company shall also

not be eligible to participate in the Bid.

11. If a company has two or more separate manufacturing units at different sites/states,

the company will be allowed to submit only one Bid for all units but necessary document

regarding separate manufacturing units will be submitted as a separate set with the same Bid.

But a bidder will be allowed to submit only one offer for one product.

15 of 51

C. TECHNICAL BID

1. The technical bid submission should be done on the following website only

https://GMSCL.nprocure.com

2. The “Technical Supporting Documents” of Tender inclusive of the “Document Fee”, “EMD”

should be submitted at the below mentioned address:-

Managing Director

Gujarat Medical Services Corporation Limited

Regd. Office: Block No.14/1,

Dr. Jivraj Mehta Bhavan, Sector-10, Gandhinagar.

Tel: 079-23250770, 23250766

Fax: 079-23257586

3. If the supplier fails to submit the supporting documents offline on or before the due date and

time of physical submission of tender supporting documents inclusive of Documents Fee and

EMD, the bidder is entitled for immediate disqualification.

4. The tenderer should invariably submit his tender in three sealed covers separately namely [1]

Document Fee Cover, [2] E.M.D. Cover [3] Technical Supporting Documents Cover. The

details of these documents to be submitted are as mentioned below in the respective heads:-

5. DOCUMENT FEE COVER

a) Payment as document fee should be made by DD o n l y , p a yab l e a t G an d h i n aga r

a t an y S ch ed u l ed b an k / n a t i o n a l i z ed ban k , i n f av o r o f G u j a r a t M ed i ca l

S e r v i ce s C o r p o r a t i o n Li m i t ed , G an d h i n aga r

b) Payment made toward document fee will not be refunded.

c) Non-payment of the document fee will make the tenderer liable for disqualifications.

d) The tenderers who are desirous of availing SSI benefits shall have to submit a letter

clarifying that they want to avail the benefits and must adhere to guidelines as mentioned

in Point (a) of General Terms & Condition ( Heading D)

6. EMD COVER

a) The E.M.D. should be paid in form of Treasury Chalan deposit under Revenue Deposit or

by Demand Draft in favour of G.M.S.C.L., Gandhinagar drawn on any bank in Gandhinagar

or irrevocable Bank Guarantee stamped with adhesive stamp of Rs.100/- issued by Schedule

Bank. The Demand Draft should be issued by bank only after date of advertisement of

tender enquiry. The Bank Guarantee will be accepted in case where the amount of E.M.D.

exceeds Rs.5000/- and such Bank Guarantee should be valid up to six month from the date

of its issuance. E.M.D. in any other forms will not be accepted. The bank guarantee for

EMD will be accepted as per government resolution of finance department.

b) Non- payment of the EMD will make the tenderer liable for disqualifications.

c) Wrong/ Fraudulent data submission may lead to disqualification / debarment. Please

ensure that you furnish correct data.

7. TENDER SUPPORTING DOCUMENT COVER:-

Please refer to General Terms and Conditions and Check List of Tender as in Annexure-X

A-Group documents should be submitted online only and B-Group documents should

be submitted physical only as per Annexure-X.


16 of 51

D. GENERAL TERMS AND CONDITIONS OF TENDER:-

1. Special Benefits for Small Scale Industries:-

Those tenderers who are desirous of availing the benefits as provided for SSI

units by Government vide GR No. SPO/102015/691093/CH dated: 03/06/2016 issued

by Industries & Mines Department:-

a) Exemption for Payment of document fee, exemption for Payment of EMD & Benefit

of Security deposit. Shall have to submit, valid Micro/small enterprise registration in

new acknowledgement (As per the Gazette of India Act-2006) issued by concerned

authority of Gujarat state along with valid certificate of CSPO / NSIC / DGS & D/KVIC (if

applicable) registration.

b) To avail the benefit of Price Preference & Price matching,

(1) Tenderers Shall have to submit a valid Micro/small enterprise registration certificate (As

per the Gazette of India Act-2006) issued by concerned authority of Gujarat state

(2) valid certificate of CSPO / NSIC / DGS & D/KVIC (if applicable) registration .

(3) Self-attested copy of Certificate from Practicing Chartered Accountant or Practicing company

Secretary that the unit / bidder still continues to be Small Scale, Tiny/ Cottage Industry should be

asked as under :

(i) MSME status for the year before the immediate previous financial year if the tenders are issued

on or before 30th September.

(ii) MSME status for the immediate previous financial year if the tenders issued on or after 30th

September.

(4) Self-attested copy of latest audited annual balance sheet and investment in plant and machinery to be

certified by the same professional.

(5) Certificate / documents mentioned in above (b) (3 & 4) should be from same professional.

C) Price preference will be calculated as per guidelines given by the Govt. of Gujarat,

Industries and Mines Dept., resolution GR No. SPO/102008/794/CH, dated 02/09/2015

(d)Main/ Parallel/ Substitute Rate Contract for procurement of stores will be fixed up as per G.R.

No. MSP/102002/3342/JH, dated 06/11/2003& dated. 04/10/2006.

2. Marketing Data & Proof of Manufacturing Experience:-

a) All the manufacturers for quoted items must have minimum preceding three years‟

experience for manufacture (after issuance of permission by concerned licensing

authority) & marketing of the quoted products on the date of opening of technical bid.

b) However, for manufacturer having preceding one year manufacturing & marketing

experience under valid license to use ISI mark for the quoted product on the date of opening

of technical bid will also be considered.

c) If the tender is scheduled to open on 01-01-2008, the three years manufacturing

experience is considered only if the first batch of quoted item is manufactured on 01-01-

2005 or earlier to that date and should have continuous production till the date of

opening of technical bid. The date of manufacture of first batch & its quantity must be

clearly shown in the second column of affidavit which must be strictly in accordance with

the performa shown in Annexure-II.

d) In case where tender is to be submitted by authorized representative/dealer for imported

drugs/surgical /diagnostic kit should be a regular supplier of a quoted product of that

manufacturer for preceding two years from the date of opening of technical bid and first

date of imported quantity and year wise imported quantity and sale in India of that item duly

supported by affidavit from importer. The report should be submitted as per Annexure-II.

e) Discontinuance of production of quoted item after a single batch or no production

thereafter will be considered as insufficient experience & the product will be disqualified.

The manufacturer must therefore submit manufacturing data separately & year wise for at

17 of 51

least preceding three years/two years/ one year (whichever is applicable) with distinct

quantity & value & number of batches strictly in the said format (Annexure-II).

f) Managing Director reserves the right to disqualify any offer if the total manufactured

quantity shown in the affidavit is apparently insufficient in relation to the approximate

purchases of last R.C.

g) The year wise quantity manufactured / imported and marketed & its sales value must also be

shown strictly as per the format in affidavit. ( Annexure-II). Details Data in Letter head of

Company is not acceptable. It must be given in affidavit duly done by a public Notary.

h) In case where item is required with ISI Mark, manufacturing and selling experience of

product having ISI mark will only be considered. But, in such a case, certified copies of

license to use ISI mark for last one year as well as latest and valid license are to be submitted

with tender. The latest license should be valid during the period of rate contract.

i) In addition to affidavit for production / import and sales, the tenderer has to furnish C.A.

Certificate (in original/Notorized) showing year wise production / import & sales for last

three years/two years/one year (whichever is applicable) for the item quoted,

otherwise offer will be rejected.

j) Authorization letter nominating a senior responsible officer of the company with authority

to transact business also to be provided with tender.

3. Turnover Criteria

(a) Bidder firm has to submit turnover certificate of chartered Accountant for last three years. [i.e. (i) 2014-15, 2015-16, 2016-17 for tender floated on or after 30th September, 2017 The Average Annual turnover of last three years should not be less than 2 crores.

(b) For SSI units of Gujarat the average annual turnover should not be less than Rs.75.00 lacs

for list of items attached at annexure.( Annexure-XIII)

(c) VAT Clearance Certificate (Last Financial Year) / Certified copy of VAT Return

Mentioning Zero Outstanding (Last Financial Year).

(d) No conditional offer / quotation will be accepted. No variation in the terms and conditions

of the tender, including deviation from standards / specifications / terms of supply will be

accepted.

4. Technical Supporting Documents for Tenders

The legible and certified copies of the following documents must be attached /annexed to

Technical Supporting Documents:-

a ) Valid Manufacturing license & Product Permission (as the case may be) for imported

products valid Manufacturing License& Product Permission of

manufacturer (as the case may be).

b) Valid Appropriate Drug License of tenderer & Valid Import License for imported Products.

c) Valid Narcotics / Explosives License. (if applicable).

d) Valid WHOGMP certificate of manufacturer.

e) (1) Micro/small enterprise Registration certificate and valid CSPO/N.S.I.C./D.G.S. &

D/K.V.I..C. (if applicable), Pl. see Condition No.4.

(2) Certified / Notarized copy of latest audited annual balance sheet and information providing their

Investment in plant and machinery to prove their present status as an SSI Unit.

f) I.S.O. certificate along with the declaration of manufacturer of the item in the location

certified by I.S.O. in the prescribed format (if applicable).

g) Valid I.S.I. certificate (if applicable)

h) Photo copy of PAN card (Permanent Account Number)

i) Prescribed affidavit showing year wise production / import & sales for preceding three years/

two years / one year (as the case may be) for items quoted in original. (As per format

18 of 51

Annexure-II)

j) Higher price / Lower price certificate. (As per format Annexure-III).

k) Non-conviction certificate (Certificate Issued within 12 months before due date of this

tender) issued by concerned Food & Drug control Authority. (Preferably as per format

Annexure-XII).

l) VAT Clearance Certificate (Last Financial Year) / Certified copy of VAT Return

Mentioning Zero Outstanding (Last Financial Year).

m) Affidavit regarding format of certificates. (As per format Annexure-IV).

n) Performance Certificate.(Certificate Issued within 12 months before due date of this tender).

from concerned Food & drug control Authority.(Preferably as per format Annexure-XI).

o) C.A. Certificate in original/ Notarized showing year wise production / import& Sales of

quoted items for preceding three years/two years/one year (whichever is applicable).

p) C.A. Certificate in original/Notarized showing year wise Turnover for last three

years[i.e. (i) 2014-15, 2015-16, 2016-17 for tender floated on or after 30th September, 2017

Authority letter in prescribed format for imported items. (As per format Annexure-VIII).

q) Verification, Undertaking checklist & Document. (As per format Annexure-I)

(ON STAMP PAPER OF Rs.20.00 & TO BE NOTARIZED)

r) Statement of capacity of production. (As per format Annexure-VII).

s) Declaration about debarment of manufacturer for the items quoted. (As Per format-

Annexure-IX)

t) Sales Tax (VAT) / CST/ Goods and Service Tax (GST) registration copy.

u) (ALL PHOTOCOPIES ARE REQUIRED IN SELF ATTESTATION

MODE EXCEPT AFFIDAVIT IN ORIGINAL ON NON JUDICIAL

STAMP PAPER DULY ATTESTED BY FIRST CLASS

MAGISTRATE/NOATARY PUBLIC) Before submission of any tender, the

tenderer must verify that they have submitted all relevant certificates / permissions /

documents in proper format along with tender. No intimation of missing documents

will be given by this office. No documents will be accepted thereafter and the

tenders will be processed on the basis of available documents / certificates. If the

requisite documents are not submitted or even if submitted are not in proper format, the

tender is liable to be rejected.

5. All documents specified must strictly be as per the format wherever the format is

prescribed in tender Document or as prescribed by concerned authority viz. FDCA, ISI,

Commercial Tax etc. and must be valid on the date of opening of tender. The documents of

drug license, C.S.P.O. registration, higher price / lower price certificate, non-conviction

certificate, Commercial Tax Clearance Certificate are to be furnished with tender. Moreover

proof of application for renewal or Challan thereof for above certificates will not be

considered in lieu of valid certificate except in case of renewal of Drug Licence.

6. The tenderer must satisfy that they are in possession of the requisite permissions / licenses /

permits required for the manufacture / supply / sale / distribution of the items as per the

specifications for which the offer is made. Failure to enter into contract if selected or to

execute the purchase orders after entering into contract for want of permission / license or due

to non-supply of certificates / documents will be viewed seriously and will invite forfeiture of

E.M.D. / risk purchase / disqualification for appropriate period without any further

reference.

7. The E.M.D. / Security Deposit shall liable to be forfeited in the following circumstances when the:

a) Tender is rejected due to failure to furnish the requisite documents in the proper format or

giving any misleading statement or submission of false affidavit or fabricated documents.

19 of 51

b) Party fails to sign the agreement for entering into contract in case the offer is accepted,

due to any reason whatsoever.

c) Party fails to supply the goods / items as per the orders placed by either this GMSCL

or by Direct Demanding Officers (DDOs) within the delivery period so stipulated;

d) Party fails to replace the goods declared to be not of standard quality or not

conforming to acceptable standards or found to be decayed / infected / spoiled before the

date of expiry have to refund the cost of such goods.

8. The claim of price revision of finished goods under any pretext or reason, including the

revision of duty / excise / cost will not be allowed at any stage after the last date of submission

of the tenders.

9. The period of the rate contract shall be approximately two years from the date of issuance of

Rate Contract. However, the Managing Director reserves the right to terminate the contract by

giving one-month notice at any time at any stage and without any reason. The rate contract will

be operated by GMSCL only. If a RC holder supplying goods upon direct purchase order from

district level officer without approval of GMSCL, it would be considered as a breach of

contractual obligation and would attract penal action which may extend up to debarment of

firm.

10. The Managing Director may extend the rate contract, subject to the same terms and

conditions. If found necessary to do so for a period not exceeding six months to which the

contractor will have to abide. However, the extension for a period more than six months can

be granted on mutual agreement by both parties.

11. Periodical Statement of Supply:-The Rate contract holder shall have to submit a quarterly

(Every three months) report of supply made to the Direct Demanding Officers and others

(Other than GMSCL).In the said report RC holder shall have to furnish the Name of institution

,Item code, Name of item, Order No &Date, Order Qty & Amount, Date of supply and supplied

qty. etc to this office. It is mandatory to provide this information to GMSCL as an integral part of

RC.

12. Whenever under this contract any sum of money is recoverable from the contractor &

payable by the contractor to the Managing Director of Gujarat Medical Services Corporation

Limited, Gandhinagar or an officer empowered by him shall be entitled to recover such sum by

appropriating in part of whole the Security Deposit paid by the Contractor, if a security being

insufficient or if no security has been taken from contractor, then the balance of the total sum

recoverable as the case may be deducted from the sum due to the contractor under this or any

other contract (with the Managing Director of Gujarat Medical Services Corporation Limited,

Gandhinagar) and remaining balance due will be recovered as arrears of „Land Revenue Dues‟.

13. The tenderer should submit statement of capacity of production as per Annexure-VII.

14. For any clarification on any of the above conditions, tenderers may contact the officers

during 3 p.m. – 4 p.m. on any working day. They may also meet the Managing Director/

Manager Procurement/DGM(Drugs) with the prior appointment.

15. Documentary evidence for the constitution of the firm such as memorandum and articles of

association, partnership deed etc. with details of name, address, telephone / fax no, e-mail

address of the firm and of the Managing Director/ Partners / Proprietor to be provided with the

tender.

16. For all items which covered under the definition of Drugs & for all procedures of tender&

finalizing the tender, the provision of Drugs &Cosmetics Act, 1940 & Rules there under

shall be applicable& considered final.

20 of 51

17. Quantity shown in column No.11 of Schedule is approx. tentative requirement of the item. It

may increase or decrease. The rates should not vary with the quantum of requirement. The

tenderer must supply the quantity as ordered by Direct Demanding Officers or by this

Corporation during the period of Rate Contract.

18. The minimum batch size of which the delivery will be accepted as shown in the Schedule. In

case, the aggregate of all the orders for which a particular batch is manufactured is less than the

minimum batch size prescribed in Schedule, the minimum batch shall be limited to the

aggregate of all the orders.

E. COMMERCIAL BID

1. The commercial bid submission should be done on the website only


2. The bids should be submitted on or before the time stipulated in tender notice at the website


3. The quoted rates should be valid for S I X months from the date of opening of technical bid. Rates

once quoted will be final and will not be allowed to be increased during the validity period

under any circumstances and for any reason whatsoever.

4. The rates quoted should be F.O.R. destination anywhere in Gujarat basis irrespective of

value of order and inclusive of all charges such as packing, delivery, insurance, inspection, etc.,

per unit of packing as shown in the enquiry document. The rates shown against the item

shall be presumed, in all cases, as the net price inclusive of all duties and sundries. No payment

against any duties / delivery charges etc. will be considered under any separate heading

under any circumstances Tenderer will also have to guarantee for regular and timely supply of

all the items.

5. For out state tenderer they can supply from Gujarat Depot provided they submit the following

documents along with the tender.

(i) Valid wholesale Drug License.

(ii) Gujarat sales Tax (VAT) registration certificate & clearance certificate.

(iii) Undertaking from where the supplies is made.

6. In no case, rates should be quoted anywhere except in Commercial Bid part. The tender will be

summarily rejected without any further processing or reference if the rates are quoted or

written at any place except at the relevant place in Commercial Bid part. In no case, rates for

any item should be quoted in Commercial Bid part for which the technical details are not given

or the items not quoted with details.

F. OPENING OF TECHNICAL AND COMMERCIAL BID

1. In the first instance only the "Technical Bid" (online) & envelope containing Technical

supporting documents will be opened by any two officers from GMSCL, Gandhinagar on the

date of opening of the tender and taken into consideration for finalization.

2. Scrutiny of the Tenders will be done as per terms & conditions of the tender, Govt.

Resolutions issued from time to time and guidelines given in the manual of office procedure

for purchase of stores by the Govt. Departments issued by Industries & Mines Dept.

Govt. of Gujarat.

3. Scrutiny of the Tenders will be done by GMSCL with support of technical evaluation

committee formed by the Board of GMSCL for the purpose. Inspection of manufacturing unit

for compliance of WHOGMP may be carried out by technical committee if needed.



21 of 51

4. The tender is liable for rejection due to any of the reasons mentioned below:

a) Non-submission of tender within stipulated time.

b) Submission of tender without Tender document fee.

c) Tender supporting document not submitted in separate envelopes as per conditions and

the envelopes are not super scribed with details of the tender enquiry and part enclosed.

d) Non-payment of Earnest Money Deposit (if not exempted).

e) Non-submission of required documents as shown in general condition and Annexure-X.

f) Conditional offers. Conditional and / or vague offers.

g) Unsatisfactory past performance of the tenderer.

h) Rates have been shown elsewhere than Commercial Bid part.

i) Items with changes / deviations in the specifications / standard / grade / packing /quality.

j) Rates are quoted in technical bid.

k) Stamp paper is not as per statutory provisions.

l) Submission of misleading / contradictory / false statement or information and

fabricated / invalid documents.

m) Tender not filled up properly as mentioned in the tender document.

n) Non-submission of authority letter in prescribed format for imported items.

o) Non submission of Micro/small enterprise Registration certificate and valid

CSPO/N.S.I.C./D.G.S. & D/K.V.I..C. (if applicable). Please see Condition Point (a) of

General terms and Conditions.

p) Non- Submission of Certified / Notarized copy of latest audited annual balance sheet and

information providing their Investment in plant and machinery to prove their present

status as an SSI Unit.

5. Subsequently, the "Commercial Bid" (online) will be opened only of those tenderers

whose Technical Bid satisfy the technical requirements of the tender and are otherwise

acceptable. The "Commercial Bid" (online) will be opened by any two officers from

GMSCL, Gandhinagar.

6. Back out from tender at any interim level during tender processing:-

Once the tender is submitted it will be the responsibility of the tenderer not to escape half

way directly or indirectly by way of raising any problems: In case of back out from the tender

process, penal action may be taken as decided by the board of GMSCL.

7. Bid Inviting Authority reserves the right to accept or reject the Bid for the supply of all or any

one or more items of the drugs bided for in a bid without assigning any reason.

8. Bid Inviting Authority, or his authorized representative (s) has the right to inspect the factories

of Bidders, before, accepting the rate quoted by them, or before releasing any purchase

order(s), or at any point of time during the continuance of Bid and also has the right to reject

the Bid or terminate/cancel the purchase orders issued and or not to reorder, based on

adverse reports brought out during such inspections.

G. ACCEPTANCE OF BID

1. The acceptance of the Bids will be communicated to the successful Bidders in writing (e-

mail/Letter) by the Bid inviting authority.

2. Immediately after receipt of acceptance letter, the successful Bidder will be required to submit

Security Deposit and agreement should be within 10days.

H. SECURITY DEPOSIT

1. Successful tenderers have to pay security deposit as specified by the Corporation in the

22 of 51

agreement letter in the form of treasury challan deposit under revenue deposit /

Demand Draft in the name of Gujarat Medical Services Corporation Limited, Gandhinagar

drawn on any bank in Gandhinagar / irrevocable bank guarantee stamped with adhesive of

Rs. 100/- valid for a period not less than 36 months at the time of entering into agreement for

the performance of the contract.

2. Failure to pay security deposit and to execute the agreement within stipulated period shall

invite disqualification of the tenderer for future quotations apart from forfeiture of E.M.D.

and being liable for penalty as deemed fit by Managing Director in relation to the tender

under process. Security deposit is payable by all the parties except by the undertakings and

corporations of the Government of Gujarat which exempted by Govt.

3. The security deposits submitted in connection with the earlier contract and which are locked

with those contracts and which have not been released till date will not be considered and fresh

security deposit separately for each item must be submitted in such cases.

4. The security deposit shall be refunded only after satisfactory execution of the contract

and recovery of dues, if any.

I. AGREEMENT

1. Successful tenderers have to enter into agreement within 10 days for due performance of the

contract. The agreement form sent by this Office should be stamped with adhesive stamp

for the requisite amount, and signed before any Gazetted Officer of this Office or before a

Ist class Magistrate or Justice of peace or Notary Public.

2. The accepted tender (AT) holder / rate contract (RC) holder should supply the items as per

specifications and packing approved by GMSCL. Otherwise the stores will not be accepted

and penal action will be taken against the AT/RC Holder.

3. All supply orders issued by the indenting offices issued on or before the last date of the

contract of the RC will have to be accepted by the RC holder and the delivery for all such

orders will have to be effected as per the schedule specified in the order, even though the date

of actual supply may fall beyond the last date of the RC.

4. The AT/RC Holder must supply the drugs and other items of stores as per the standards of

quality mentioned in second schedule of Drugs &Cosmetics Act, 1940 & respective

pharmacopoeia. The stores must continue to confirm to the usual pharmacopoeia limits of

potency, if tested at any time during its shelf life till its expiry date.

J. SUPPLY CONDITION

1. Purchase orders along with the delivery destinations will be placed on the successful Bidder at

the discretion of the Ordering Authority. Drugs and Medicines will be supplied at any place

across the State as mentioned in the Purchase Order.

2. The Tenderer must submit a test analysis report from a NABL laboratory/ Govt. approved

(FDCA Approved) public testing laboratory for every batch of drug along with consignment.

However, if the tenderer submits a report from GLP compliant in-house testing

laboratory, the supplies would be accepted subject to a reduction of two weeks in the

permissible delivery period from that mentioned in point (c) below.

3. Delivery Period: Unless specified in the tender or instructed by the managing Director, the

maximum delivery period shall be eight weeks for all the items, except for all injectable item

and sterile category items delivery period will be ten weeks However, the Managing Director

may extend the delivery period in slabs of two weeks up to maximum of 12 weeks for orders of

23 of 51

large quantity.

4. For this purpose, the extension in delivery period shall be given as per the prevailing policy

framed by Managing Director, GMSCL or the Concerned Purchase Order committee. The

maximum delivery period will be counted from the next working day after the actual date of

posting the order provided that the Managing Director, may at his discretion, may procure

20% of the order immediately and balance quantity of the order within 4 weeks to meet

any situation of exigency / epidemic / calamity.

5. Risk Purchase:- The risk purchase of the items ordered at the cost and risk of the party will

be carried out when the party fails to:

a) Sign the agreement for entering into contract due to any reason whatsoever in case the offer

is accepted.

b) Supply the goods / items as per the order placed by either this corporation or by direct

demanding officers in accordance with the main / parallel / substitute rate contracts, either

during the prime / extended validity period or within the delivery period stipulated above.

c) The Risk Purchase will be done at any time after the delivery period is over.

d) The Risk Purchase will be done from Main / Parallel or Substitute R.C. holder for

undelivered quantity of the Stores & the Contractor shall be penalized to the extent of

10% or difference whichever is higher.

6. GMSCL would also place direct supply order to other organizations/ CPSEs as per govt. norms

in case:-

a) Tenders/ offers are not received or

b) Tenders are not finalized due to any reason or

c) RC holder supplier fails to supply the required / ordered quantity or

d) In case of Emergency or Epidemics.

In aforesaid circumstances quotations will be invited from all the CPSEs and placed before

concerned procurement committee for decision.

7. Under such circumstances difference will be recovered from the concerned RC holder who

failed to supply.

8. The order stands cancelled after the expiration of delivery period, and if the extension

is not granted with or without liquidated damages.

9. It shall be the responsibility of the supplier for any shortage/ damage/ breakages at the

time of receipt at the designated places.

10. If at any time the Bidder has, in the opinion of the ordering authority, delayed in making

any supply by reasons of any riots, mutinies, wars, fire. Storm, tempest or other exceptional

cause on a specific request made by the Bidder within 7 days from the date of such

incident, the time for making supply may be extended by the MD, GMSCL at his discretion

for such period as may be considered reasonable. The exceptional causes do not include

the scarcity of raw material, Power cut, Labour disputes.

11. The supplier shall not be in any way interested in or concerned directly or

indirectly with, any of the officers, subordinates or servants of the Bid Inviting Authority

in any trade or business or transactions nor shall the supplier give or pay promise to give

or pay any such officers, subordinates or servants directly or indirectly any money or fee or

other considerations under designation of “Customs” or otherwise, nor shall the supplier

permit any person or persons whom so ever to interfere in the management or

performance hereof under the power of attorney or otherwise without the prior consent in

writing of the Bidder Inviting Authority.

24 of 51

12. In case of item having pharmacopeial Standard the brand name of item or abbreviations

indicating the same can be printed anywhere on both internal / external packing. However

the font size of such brand name or abbreviation printed on internal / external packing

should not be more than 50% as compared to the generic name. The supplier would have

to produce an undertaking regarding the same at any time prior to make the supply.

13. The RC holder shall have to supply the drugs with different color, coding, packing,

labelling as well as display of rates on packaging as and when required by GMSCL.

14. Notwithstanding various action and penalties for non-supply and / or delayed supply of the

Drugs. GMSCL shall take action against the supplier as follows:

a) If the supplier fails to execute at least 70% of the ordered quantity as mentioned in a

single Purchase order and such part supply for any three Purchase orders of the same

drug, then the product of the supplier will be debarred and becomes ineligible to

participate in any of the tenders for that particular item(s) by GMSCL for a period of 2

year from the date of intimation for debarrement besides forfeiture of security deposit

of that product(s).

b) If the supplier supplies more than one item and 50 % of such items are debarred, the

firm is liable to be debarred for a period of 2 years from the date of intimation of

debarment besides forfeiture of security deposit in full.

c) Purchase orders, if any, already issued before taking any blacklisting action or orders

given in past will not be affected in view of action taken as per above guidelines but all

strict quality checks shall be observed for each supply of products.

K. Shelf Life

1. The expiry period of Drugs and other items should not be less than two years unless prescribed

under statutory provisions or schedule "P" in which case it shall not be less than the maximum

prescribed under statutory provisions or Schedule "P" as the case may be.

2. In case where expiry period of drug /item is up to two years, it should not have lapsed the 1/6th

of shelf life at the time of delivery. And in case where expiry period is more than two years it

should not have lapsed 1/4th

of Shelf life at the time of delivery.

3. In case of emergency for products having expiry period 2 years or more Managing Director,

GMSCL, reserves right to accept the goods after getting the written confirmation from RC

holder to take back the unutilized quantity with penalty of 2% of total supply value per month

which have lapsed shelf life mentioned above.

4. In no case stores whose 2/6th

shelf life has lapsed shall be accepted.

5. However the Managing Director GMSCL reserves the right to waive off penalty if the

remaining shelf life of product to be supplied is more than what has been sought in the

tender document.

6. Moreover in case of imported item like vaccine, serum, etc. Managing Director, GMSCL,

reserves right to accept the goods with applicable penalty for packing deviation if any,

after getting the confirmation from the firm to take back unutilized quantity after expiry.

7. In case where product is being supplied does not confirm to the packing standard for e.g.

logo , MRP, Packing size etc.) GMSCL reserves the right to reject the goods.

However if MD GMSCL is satisfied that such packing deviation is non critical in

nature and does not effect the quality of the product, he may with the reason

recorded in writing, accept such goods with the minimum penalty of 3 % for each

such deviation.

8. The stores which have already lapsed shelf life mentioned above will not be accepted.

25 of 51

9. The stores with unpacked or in loose condition will also be not accepted under any

circumstances.

10. Only those bidders shall quote who can manufacture and supply the product with the

required shelf life. The product of labeled shelf life lesser than required shelf life will

not be accepted

11. Quality Assurance: The supplier shall guarantee that the products as packed for shipment (a)

comply with all provisions of specifications and related documents (b) meet the recognized

standards for safety, efficacy and quality; (c) are fit for the purpose made; (d) are free from

defects in workmanship and in materials and (e) the product has been manufactured as per

GMP included in Schedule M of Drugs & Cosmetic Rules.

12. The protocol of the tests should include the requirements given in I.P for tablets and those

required specifically for the product specifications. The Bidder must submit its Test/ Analysis

Report for every batch of drug along with invoice. In case of failure on the part of the

supplier to furnish such report, the batch of drugs will be returned back to the supplier and

he is bound to replenish the same with approved laboratory test report. The supplier shall

provide the validation data of the analytical procedure used for assaying the components and

shall provide the protocols of the tests applied and the placebo material when demanded for the

purpose of testing.

13. The Drugs and medicines supplied by the successful Bidder shall be of the best quality and

shall comply with the specification, stipulations and conditions specified in the Bid documents.

L. PACKING AND LOGOGRAMS

1. The packing, strip and blister of Tab. / Cap. and the labels of all the drugs or other items to be

supplied under the order should be permanently and prominently printed in English & Gujarati

with the words: “FOR THE USE OF GOVT. OF GUJARAT. NOT FOR SALE.” “ U]HZFT

;ZSFZGF p5IMU DF8[ J[RF6 DF8[ GCL” along with logogram. The logogram must be distinct from the

normal trade packing. If the items are packed in packets which are then placed or repacked in a

box / carton / sachet / bottle / foil, these words will be permanently and prominently printed

on both the internal/ external packs and labels along with logogram. The M.R.P. or any other

price must not be printed or not to be shown anywhere either on external pack / box / carton/

foil or on internal packing.( As per Annexure-VI)Logograms /Markings

Logogram means, wherever the context occurs, the design as specified below:-

2. Packing

a) The item shall be supplied in the package schedule given below and the package shall carry the

logogram specified as specified above. The labeling of different packages should be as

specified below. The packing in each carton shall be strictly as per the specification mentioned.

Failure to comply with this shall lead to non-acceptance of the goods besides imposition of

penalties.

b) The pediatric drops should always be supplied with dropper. A measuring cap with suitable

markings must be provided for other paediatric oral liquid preparations.

c) The labels in the case of injectables should clearly indicate whether the preparations are meant

26 of 51

for IV, IM, SC, etc.

d) Injection vials should have flip off seals. The ampules should be provided with ampule foil.

e) Small tablets packed in blisters should be so packed to facilitate removal of tablets without

breaking or crushing.

f) All plastic jars above 450gm/ml should carry an inner plastic lid.

g) The cap of bottles of preparation should not carry the name of the supplier.

h) The medicines stores between 2 to 8 degree (cold and cool storage) Centigrade shall have to

supply in appropriate storage/ transport condition using cold chain supply.

i) All plastic containers should be made of virgin grade plastic.

j) The G e n e r i c name of the drug should be printed in clearly legible bold letters (It is

advisable that the colour of font be different from other printed matter to make the name

highly conspicuous.

k) It should be ensured that only first hand fresh packaging material of uniform size is used for

packing. All packaging must be properly sealed and temper proof.

l) All packing containers should strictly conform to the specifications prescribed in the relevant

pharmacopoeia/Act.

m) Packing should be able to prevent damages or deterioration during transit.

n) In the event of items supplied found to be not as per specifications in respect of their packing,

the stores will not accept the goods.

o) All containers i.e. bottles, tins, cartons, tubes etc. must be secured with pilfer proofs seals to

ensure genuineness of the products packed and the correctness of the contents."A" type plastic

container should conforms to IS:7803 (Part I): 1975 and Polythene plastic bag (Except for

intravenous fluids) should conforms to IS:10141 : 1982.

4. SCHEDULE FOR PACKAGING OF DRUGS AND MEDICINES

GENERAL SPECIFICATIONS

a) No corrugate package should weigh over 15 kgs (i.e. product + inner carton +corrugated

box).

b) All items should be packed only in first hand strong boxes only.

c) Every corrugated box should preferably be of single joint and not more than two joints.

d) Every box should be stitched using pairs of metal pins with an interval of two inches

between each pair.

e) The flaps should uniform meet but should not overlap each other. The flap when turned by 45-

60 should not crack.

f) Every box should be sealed with gum tape running along the top and lower opening.

g) The final packing of cartons of corrugated boxes shall be complying with IS:9313 : 1979 of

November, 1980.

5. CARRY STRAP:

Every box should be strapped with two parallel nylon carry straps (they should intersect.)

6. LABEL:

a) Every corrugated box should carry a large outer label clearly indicating that the product is for

“Govt of Gujarat Supply-Not for Sale” with Logogram of GMSCL.

b) The Product label on the cartoon should be large, atleast 15 cms x 10 cms dimension. It

should carry the correct Generic name, strength or the product, date of manufacturing, date

of expiry quantity packed and net weight of the box. OTHERS:

c) NO box should contain mixed products or mixed batches of the same product.

27 of 51

7. SPECIFICATION FOR CORRUGATED BOXES HOLDING TABLETS/

CAPSULES/ PESSARIES

The total weight of the box should be approx of 7-8 Kgs.

8. SPECIFICATION FOR LARGE VOLUME BOTTLE i.e., ABOVE 100 ml AND

BELOW 1 LIT.

All these bottles should be packed only in single row with partition between each and also

with top and bottom pad of 3 ply.

9. SPECIFICATION FOR IV FLUIDS

Each corrugated box may carry maximum of only 24 bottles of 500 ml in a single row or 50

bottles of 100 ml in 2 rows with individual sealed polythene cover and centre partition pad, top

and bottom pads of 3 ply.

10. SPECIFICATION FOR LIQUID ORALS

a. 100 bottles of 50 ml or 60 ml may be packed in a single corrugated in 2 rows with top, bottom

and centre pad of 3 ply.

b. 50 bottles of 100 ml – 120 ml may be packed in a similar manner in a single corrugated box.

c. If the bottles are not packed in individual carton, 3 ply partition should be provided between

each bottle. The measuring device should be packed individually.

11. SPECIFICATION FOR OINTMENT/ CREAM/GELSPACKED IN TUBES:

a. No corrugated box should weigh more than 7-8 Kg.

b. Every Ointment/Cream/Gel tube should be individually packed in carton and then packed in

20‟s in a grey board box, which may be packed in a corrugated box.

12. SPECIFICATIONS FOR INJECTION (IN VIALS AND AMPOULES)

a. Vials may be packed in corrugated boxes weighing up to 15 Kgs. Ampoules should be

packed in C. B. weighing not more than 8 Kgs.

b. In the case of 10 ml Ampoules or 50 ampoules may be packed in a grey board box. Multiples

of grey board boxes packed in CB. In case of ampoules larger than 10 ml only 25 ampoules

may be packed in a grey board box with partition. If the vial is packed in individual cartoon,

there is no necessity for grey board box packing. The individual cartoon may be packed as

such in the CB with centre pad.

c. In case of ampoules every grey board box should carry 5 amps along with Cutters placed

in a polythene bag.

d. Vials of eye and ear drops should be packed in a individual cartoon with a dispensing device.

If the vial is of FFS/BFS technology, they should be packed in 50‟s in a grey board box.

e. Cutters are not required with ampoules in the case of snap off type ampoules.

13. SPECIFICATION FOR ORS

Primary Packing:- The pouches/sachets of ORS should be three layered with following

composition

Site Material Micron MM g/m

2

Inner Polyethylene 50 0.040-0.050 36.9-46.1

Middle Aluminium 09 0.009-0.015 24.3-40.5

Outside Polyester 12 0.012-0.015 12.9-20.9

28 of 51

Secondary Packages and Tertiary package:- 50 sachets may be packed in grey board boxes and

10 grey board boxes in a Corrugated Box.

M. QUALITY TESTING

1. Sampling of supplies from each batch will be done at the point of supply or distribution/storage

points for testing. (The samples would be sent to different empanelled laboratories for testing

by the ordering authority after coding). The GMSCL will deduct a sum of 1% from the amount

of bill payable to supplier on account of handling and testing charges.

2. The Drugs shall have the active ingredients within the permissible level throughout the

shelf life period of the drug. The samples may also be drawn periodically during the shelf life

period. The supplies will be deemed to be completed only upon receipt of the quality

certificates from the laboratories.

3. Samples which do not meet quality requirements shall render the relevant batches liable to be

rejected. If the sample is declared to be Not of Standard Quality or spurious or adulterated or

misbranded, such batch/batches will be deemed to be rejected goods.

4. The supplier shall furnish to the purchaser, the evidence of bio-availability and bio-equivalence,

polymorph screening report, report of assay and impurities should be submitted for certain

critical drugs when asked for.

5. The products should conform to the standards of IP/BP / USP as the case may be. In case the

product is not included in the said compendium, the supplier, upon award of the contract, must

provide the reference standards and testing protocols for quality control testing. For imported

drugs respective countries pharmacopeia standards shall be acceptable (even if the product is

official in IP).

6. The supply of any item shall be considered complete for the purpose of calculation of

liquidated damages only when reference standards/ standard testing procedure or test

protocol/placebo materials are made available to the corporation along with the supply of

items as per the purchase order. However, these materials and documents shall be made

available by supplier to Quality Cell of GMSCL Headquarter. Such requirement will

communicated by the Headquarter as and when required.

7. In case where the order is placed by Direct Demanding Officer, the sample will be collected by

Drug Inspector of the district or any other officer empowered by him and will be sent for

testing. The decision of the competent drugs control authority will be conclusive and final

and binding to the A.T. / R.C. Holder.

8. If any item is found apparently spoilt / decayed / infected till the expiry date or in case of any

compliant from G.M.S.C.L. / Direct Demanding Officers, the Contractor shall be liable to

replace the unutilized quantity even if the sample is not tested.

9. The samples of stores to be supplied against this rate contract will be drawn by an authorized

person so nominated by the Managing Director, GMSCL, and tested at a laboratory

approved and licensed by the Commissioner, FDCA and nominated by the Managing

Director, GMSCL. The goods will be accepted only if declared to be acceptable as per second

schedule of Drugs & Cosmetics Act, 1940 & respective pharmacopoeia by the said laboratory;

otherwise the supplier will have to take back the goods at his cost. The decision of the

Managing Director will be final and conclusive and no retesting will be allowed. It is further

clarified that such pre-testing will be in addition to the sample testing described in sub-point

(a) of point M(Namely Quality Testing) and will be independent of the replacement /

recovery provisions described in the tender document.

10. It is further clarified that wherever there is a difference in the report of the testing laboratory and

29 of 51

that of the laboratory notified under the Drugs & Cosmetics Act 1940, the latter shall prevail to

the exclusion of the former and no claim whatever based upon the former will be entertained.

11. Further Tenderer should give a written declaration–cum-consent that they shall not supply

rejected drugs to any other Government Organization /Direct Demanding officer. Failing to

which will invite termination of Rate Contract and/or shall be debarred by GMSCL.

12. Replacement Clause:

Note: This clause shall be applicable to sampling & testing under Drugs & Cosmetics

Act, 1940 by notified Drugs Inspector & Govt. Analyst respectively.

If any stores supplied against the A.T./R.C. are found to be of not of standard quality on

inspection and / or analysis by the competent authority, the contractor shall be liable to replace

the entire quantity of the relevant batch within 4 weeks or make full payment of the entire

consignment against the particular invoice, irrespective of the fact that part or full quantity

(batch) of the stores supplied may have been consumed. The decision of the Managing

Director, GMSCL taken on the basis of the report of the competent laboratory regarding

quality will be final and binding. The stock of any item, which has been declared, not of

standard quality shall be withdrawn from all the indenters and will not be returned to the

contractor but will be destroyed by the Organization and the contractor, shall have no claim

over such stores.

Moreover, looking to the time period lapsed in retesting procedure at Central Drugs

Laboratory:-

a) The replacement as aforesaid will not be accepted where retesting is demanded by R.C.

Holder, but only recovery will be done by issue of recovery order so that the questions of

payment of replaced goods does not arise in case the sample is declared standard by Central

Drugs Laboratory. The recovery order as aforesaid is revocable when the batch passes in

retesting.

In case of retesting of substandard drugs, whenever the date of receipt of the test report of

Central Drugs Laboratory, Calcutta declaring the batch as standard quality is close to the

expiry of the batch, Managing Director, G.M.S.C.L., cannot hold the responsibility to use the

unconsumed goods. Under such circumstances the R.C. Holder will have to replace the

unconsumed goods either fully or partially as instructed by Managing Director, G.M.S.C.L.,

and such decision of Managing Director, G.M.S.C.L., based on (a) the duration of reuse and

(b) quantity of unconsumed goods, will be binding on the R.C. Holder.

b) The contractor shall have no claim over unconsumed goods, which shall be destroyed

on the basis of result from Drugs Laboratory, Baroda or shall have no claim over value

thereof.

c) The contractor will not be liable for refund due to unconsumed stock which is very near (3 to

6 months as the case may be depending upon the quantity) to expiry date at the time of receipt

of CDL Report. Refund of only consumed goods will be given in such cases.

Neither, claim for relaxation of replacement period nor for return of goods declared to be not

of standard quality nor any request for acceptance of the replacement goods delayed after the

delivery period (of 4 weeks), due to any reason whatsoever, will be entertained.

N. PAYMENT PROVISION

1. No advance payment towards costs of drugs, medicines etc., will be made to the Bidder.

2. On receipt of the prescribed consolidated invoice duly stamped and signed by authorized

signatory and analytical laboratory report regarding quality, the payment would be made in 30

days.

3. The in charge of district drug warehouse (REGIONAL WARE HOUSE(RWH)) will

acknowledge the drugs received & ensure entry in e- Aushadhi software online.

4. All bills/ Invoices should be raised in duplicate and in the case of excisable Drugs and

30 of 51

Medicines; the bills should be drawn as per Central Excise Rules in the name of the

authority as may be designated. The supplier will deliver following document at the time of

delivery at REGIONAL WARE HOUSE(RWH).

a) In house test report of drug.

b) The challan / invoice copy pertaining to REGIONAL WARE HOUSE (RWH)

5. Payments for supplies will be considered a f t e r receipt of reports of standard quality on

samples having been tested approved laboratories of ordering authority.

6. The bills / invoices are required to be submitted specifying the following details in

appropriate places of the invoices:

a) No. and date of bills or invoice.

b) No. and date of drug license.

c) No. and date of A.T. / R.C.

d) No. and date of order.

e) Name and specification of item.

f) Name of manufacture & Model / Make / Brand.

g) Quantity.

h) Total cost; and

i) Other details like batch , packing unit etc.

j) No. & date of challan (If supply made by challan.

7. The billing shall be in the name of the A.T. / R.C. Holder. The supplies shall be allowed by

authorized dealer as per Rate Contract. Invoice shall be in the name of A.T. / R.C. Holder.

8. The A.T./R.C. Holder shall not charge C.S.T. /VAT, if concerned authority has exempted

them. Further they cannot charge excess amount of Commercial Tax.

9. An amount of Commercial Tax as applicable to be shown separately in the bill/invoice raised.

Further an amount of Commercial Tax so collected should be remitted to the Govt. within

prescribed time limit, otherwise strict action will be taken against defaulters.

10. The payment against supply of stores shall be made within 30 to 45 days from the date of

receipt of the goods in good and acceptable conditions at the destination. However, no

interest will be chargeable by the A.T./R.C. Holder, if the payment is delayed.

11. The payment of the bill shall be made after deducting Government/Corporation dues, if any.

12. The payment of the bills shall be withheld in the following circumstances:

a) The goods are found sub-standard or in non-acceptable conditions.

b) Breach of condition of any contract by the A.T./R.C. Holder.

c) Previous Government dues of A.T./R.C. Holder.

13. Penalty:

a) Unless the penalty is waived by the Managing Director, the A.T./R.C. Holder shall have to

pay the penalty at the rate ½% (half percent) of value of stores per week maximum up to 4

week. On event of failure to supply within delivery period the supplies shall be allowed

with 10 % of penalty for undelivered quantity of stores. in the case the delivery of stores is

not affected within the delivery period.

b) The risk purchase of the items ordered at the cost and risk of the party will be carried out

when the party fails to:

(1) Sign the agreement for entering into contract due to any reason whatsoever in case the offer

is accepted.

(2) Supply the goods / items as per the order placed by either this corporation or by

direct demanding officers in accordance with the main / parallel / substitute rate contracts,

either during the prime / extended validity period or within the delivery period stipulated

above:

31 of 51

(3) The Risk Purchase will be done at any time after the delivery period is over.

(4) The Risk Purchase will be done from Main / Parallel or Substitute R.C. holder

for undelivered quantity of the Stores& the Contractor shall be penalized to the extent of

10% or difference whichever is higher.

(5) GMSCL would also place direct supply order to other organization/ CPSEs as per

government norms in case:-

a. Tenders/ offers are not received or

b. Tenders are not finalized due to any reason or

c. RC holder supplier fails to supply the required / ordered quantity or.

d. In case of emergency / epidemic.

In aforesaid circumstances quotations will be invited from all the CPSEs and placed before

concerned procurement committee for decision. Under such circumstances difference will be

recovered from the concerned RC holder who failed to supply.

c) Any monetary claim arising due to any of the terms and conditions of the tender / supply,

including the difference arising due to risk purchase, will be recovered in the following

manner:-

1) From any pending bills of the party:

2) From any security deposits of the party:

3) If an amount at 1) & 2) is not sufficient to meet an amount of recovery of dues shall be

recovered as arrears of land Revenue Dues under provisions of relevant act.

O. FALL CLAUSE:

1. Attention of the bidders is invited to the higher / lower price certificate and all the bidders /

A.T. / R.C. Holder will have to abide by the terms strictly in accordance with those mentioned

in that certificate. It must be distinctly understood that in case of supply to any institution /

department at price lower than the contracted price within the period specified in the

certificate will immediately invite the reduction in the rates of the contract.

2. Breach of any clause of the certificate will be viewed seriously and action will be taken

against the R.C. / A.T. Holder which may include forfeiture of E.M.D. / S.D., termination of the

contract and disqualification from participating in future business.

P. STANDARD BREACH CLAUSE:

1) The Managing Director of Gujarat Medical Services Corporation Limited, shall in addition to

his powers other clause to terminate this contract have power to terminate his liability there

under of the time by giving one month‟s (or such shorter period as may be mutually agreed):

notice in writing to A.T. / R.C. Holder of his desire to do so and upon expiry of notice the

contract shall be terminated without prejudice to the right accrued to the date of the

termination. However, if the Government decided to put an end to the business relations on

breach of any conditions of the contract, no such notice shall be necessary and on event of

Govt. deciding to terminate the business and the Rate Contract shall stand terminated with

immediate effect.

2) The Rate Contract can also be terminated by the Managing Director in the following

circumstances:

a) If the firm is debarred or disqualified or ceases to exist or convicted of any offence.

b) If the quality of the item to be supplied is found not up to the standard and multiple samples

are found to be not of standard quality.

32 of 51

Q. INSPECTION:

Inspection shall normally be carried out in the premises of the consignee. If goods are offered

for inspection in the factory premises all expenditure shall be borne by the A.T. /R.C. Holder.

The entire store ordered shall have to be offered for inspection in open condition if required and

the same shall be repacked in presence of inspecting team. All packing should be sealed and

signed by inspecting authority and sent to the consignee without any extra cost within three days

from the date of receipt of inspection note. Inspection charges, including the expenses for the

experts, will be payable by the party as per the rates prescribed in the letter of agreement and as

determined by the L.L.C./M.D.L.C./H.L.P.C./B.L.C. from time to time.

R . WARRANTY CLAUSE:

The A.T. / R.C. Holder shall be subjected to the following warranty clause that the

goods/stores/article sold to the buyer under this contract shall be of the best quality to

workmanship and shall be strictly in with the specifications and particulars contained/mentioned

in the acceptance of tender and the contract/seller would continue to confirm to the

description and quality of for period of the shelf life for the product and notwithstanding the

fact that the purchaser (inspector) may have inspected and / or approved the said goods / stores /

articles be discovered of the purchaser in that behalf will be final and conclusive the

deteriorated and the decision of the purchaser will be entitled to reject the said goods / stores /

articles or such portion rejections the goods /stores / articles will be at the sellers risk and all

the provisions here in contained relating rejection of goods etc. shall apply. The contractor /

seller shall if, so called upon to do replace within a period of month of such further period as

may be extended from time to time by the purchaser in its discretion on an application made

thereof by the contractor / seller the goods / stores / articles or such portion thereof is its rejected

in by the purchaser and in such on even above mentioned warranty period shall be pay to

purchaser such damages as may arise by reasons for the breach of the conditions herein

contained. Nothing herein contained shall prejudice any other right of the purchaser in that behalf

under this contract or otherwise.

S. JURISDICTION:

The jurisdiction of any dispute will be Gandhinagar or Ahmedabad.

33 of 51

ANNEXURE - I

Verification, Undertaking, Checklist & Documents


From: M/s. No.

To: The Managing Director,

Gujarat Medical Services Corporation Limited,

Regd. Office: Block No.14, Dr.Jivraj Mehta Bhavan

Sector-10, Gandhinagar-382 010.

Sub: Supply of Drugs / Medicine / Surgical goods etc.

Ref: Tender Enquiry #

Sir,

I/We enclose the priced tender form duly signed & Stamped. Necessary documents are

enclosed herewith (in order in which are mentioned). The rates quoted against each item are

inclusive of excise duties and other charges. I/We shall abide by all these conditions. I/We hereby

undertake to supply the goods to the consignees as per the terms of the A.T./R.C.

I/We verify that the copies of the certificates / documents attached herewith are authentic

true copies of the original certificates / documents and I/We undertake to produce the original

certificates / documents for verification on demand. I/We undertake to supply the attested copies of

certificate / documents required at the time of signing the letter of agreement if my/our offer is

accepted.

I/We verify that I/We are in possession of the requisite licenses / permits required for the

manufacturer / supply / sale /distribution of the items and further verify that the said licenses /

permits have not been revoked /cancelled by the issuing authorities and are valid as on date. I/We

also verify that I/We have not been blacklisted / debarred / stopped from supply of the items quoted

in the Tender Enquiry by any Government Department / Organization / undertaking in India.

I/We also take cognizance of the fact that providing misleading or questionable information

or failure to furnish correct or true information to you or any other Direct Demanding Officer or

failure to comply with any contractual requirement laid down by you / them will be considered as a

serious breach of the terms and conditions of the tender and will invite disqualification and other

penal action as deemed fit by the Government / Purchase Committee, G.M.S.C.L.

Thanking you,

Date:

Yours faithfully,

34 of 51

ANNEXURE-II (REF.

CLAUSE NO.12)

(FORMAT OF AFFIDAVIT OF PROOF OF MANUFACTURING EXPERIENCE

MARKETING DATA)


I .age . residing at

. in capacity of M/s.

.hereby solemnly affirm that…..

1. M/s. . have manufactured / imported sold &

paid Commercial Tax on the said sales of their products as detailed below:

Sr.

No.

Name of Item Very first batch

of product

manufactured /

imported for

marketing

Year wise

period

Continuance of production &

marketing of year wise

Date Qty. Mfg/

Importe

d

quantity

Total

Nos of

commer

tial

Batches

Sold

Qty

.

Sale

Value

{Rs.

Lakhs}

2015-2016

2016-2017

2017-2018

2. That on the basis of the above facts & figures M/s. has

manufactured / marketed their above products the period at least year{s} prior to the due date of

Tender Enquiry No. as per the specifications mentioned in the tender.

Whatever stated above is true & correct to the best of my knowledge & belief.

Date: {SIGNATURE & STAMP OF THE AUTHORISED SIGNATORY}

35 of 51

ANNEXURE – III

HIGHER PRICE / LOWER PRICE CERTIFICATE

1. I/We . hereby certify

that the prices quoted by us in Tender Enquiry # . are not higher than the prices:

{a} charged by us to wholesalers or for institutional supplies;

{b} allowed under D.P.C.O. for wholesale / institutional supplies {where

applicable}.

2. I/We further certify that I/We have not supplied or quoted for any item in Tender Enquiry #

. at prices lower than those quoted for the relevant items to any Government

/Semi Government / Public / Charitable Trust Organization / Institution within the period of

180 days preceding the last date of submission of the tender.

3. I/We hereby undertake that I/We will not supply or quote for any item in Tender Enquiry #

. at prices lower than those quoted for the relevant items to any Government /

Semi Government / Public / Charitable Trust Organization / Institution within the period of

validity of the offer / rate contract.

4. I/We also undertake to bring to the attention of the Managing Directorany incidence of

breach of any of the above paras within 30 days from the occurrence of the breach and

further undertake to refund / reimburse the difference which may arise due to breach of any

of the above paras and I/We also understand that the decision of Managing Directorregards

to the determination of quantum payable shall be final.

Date: {SIGNATURE &STAMP OF THE AUTHORISED SIGNATORY}

Gujarat Medical Services Corporation Limited (A Government of Gujarat Undertaking)

Gandhinagar.

ANNEXURE-IV

Affidavit

(TO BE SUBMITTED PHYSICALLY)

(To be submitted IN ORIGINAL on Non-Judicial Stamp Paper of Rs.100/- duly attested by

First Class Magistrate / Notary Public)

I/We ___________________________________ Age_________ years residing at

_________________________________ in capacity of _____________________________________ M/s.

__________________________________________ hereby solemnly affirm that

1 All General Instructions, General Terms and Conditions, as well as Special Terms & Conditions

laid down on all the pages of the Tender Form, have been read carefully and understood properly

by me which are completely acceptable to be and I agree to abide by the same.

2 I / We have submitted following Certificates / Documents for T.E. as required as per General

Terms & Conditions as well as Special Terms & Conditions of the tender.

Sr. No. Name of the Document

1

2

Onwards

3 All the Certificates / Permissions / Documents / Permits / Affidavits are valid and current as on

date and have not been withdrawn / cancelled by the issuing authority.

4 It is clearly and distinctly understood by me that the tender is liable to be rejected if on scrutiny

at any time, any of the required Certificates / Permissions / Documents / Permits / Affidavits is /

are found to be invalid / wrong / incorrect / misleading / fabricated / expired or having any

defect.

5 I / We further undertake to produce on demand the original Certificate / Permission / Documents

/ Permits for verification at any stage during the processing of the tender as well as at any time

asked to produce.

6 I / We also understand that failure to produce the documents in "Prescribed Proforma"

(wherever applicable) as well as failure to give requisite information in the prescribed Proforma

may result in to rejection of the tender.

7 My / Our firm has not been banned / debarred / black listed at least for three years (excluding

the current financial year) by any Government Department / State Government / Government of

India / Board / Corporation / Government Financial Institution in context to purchase procedure

through tender.

8 I / We confirm that I / We have meticulously filled in, checked and verified the enclosed

documents / certificates / permissions / permits / affidavits / information etc. from every aspect

and the same are enclosed in order (i.e. in chronology) in which they are supposed to be

enclosed. Page numbers are given on each submitted document. Important information in each

document is "highlighted" with the help of "marker pen" as required.

9 The above certificates / documents are enclosed separately and not on the Proforma printed from

tender document.

36 of 51


Gandhinagar.

10 I / We say and submit that the Permanent Account Number (PAN) given by the Income Tax

Department is _________________________________ which is issued on the name of

______________________________________________ [kindly mention here either name of the Proprietor (in

case of Proprietor Firm) or name of the tendering firm, whichever is applicable].

11 I / We understand that giving wrong information on oath amounts to forgery and perjury, and

I/We am/are aware of the consequence thereof, in case any information provided by us are

found to be false or incorrect, you have right to reject our bid at any stage including forfeiture of our EMD/PBG/cancel the award of contract, in this event. This office reserves the right to take

legal action on me/us.

12 I / We have physically signed & stamped all the above documents along with copy of tender

documents (page no _________ to __________

13 I / We hereby confirm that all our quoted items meet or exceed the requirement and are

absolutely compliment with specification mentioned in the bid document.

14 My / Our company has not filed any Writ Petition, Court matter and there is no court matter filed

by State Government and its Board Corporation, is pending against our company.

15 I / We hereby commit that we have paid all outstanding amount of dues / taxes / cess / charges /

fees with interest and penalty.

16 In case of breach of any tender terms and conditions or deviation from bid specification other

than already specified as mentioned above, the decision of Tender Committee for disqualification

will be accepted by us.

17 Whatever stated above is true and correct to the best of my knowledge and belief.

Date: Stamp & Sign of the Tenderer

Place: (Signature and seal of the Notary)

37 of 51


Gandhinagar.

ANNEXURE-V

Gujarat Medical Services Corporation Limited,

Gandhinagar.

1. All Glass bottles should be new neutral Glass.

2. Small Tablets Packed in blisters should be so packed to facilitate

removal of the tablet without breaking/crushing.

3. All plastic containers should be made of virgin grade plastics.

4. All plastics jars above 450 gm./ml. should carry an inner plastic lid.

5. Packing should be able to prevent damage or deterioration during transit.

6. The medicines stored between 2o

C to 8o

C shall have to supply in

thermocol box with Ice pack.

7. The Cap of bottles of preparation should not carry the name of the

supplier.

8. The labels in the case of injectables should clearly indicate

whether the preparations are meant for IV, IM, SC etc.

9. Only first use packing material of uniform size including bottle and vial

is used for making supplies.

10. The tenderer must submit a test analysis report from a NABL

laboratory/Government Approved (FDCA Approved)Public Testing

laboratory for every batch of drugs along with consignment.

11. All primary packing, containers should be strictly conforming to the

specifications, included in the relevant Pharmacopoea.

12. In case a box of 100 Strips, 10 Strips should be packed with paper

Strip / Cellopham / Rubber band.

13. For Oral dosage liquid preparation, a measuring cap must be

provided with suitable markings.

38 of 51


Gandhinagar.

ANNEXURE-VI

SPECIMEN LABEL

FOR

OUTER CARTON

GUJARAT GOVT.

SUPPLY NOT

FOR SALE

U]]H]]HZFT ;ZSFZGF p5IMU DF8[[[[ v J[[R[[RF6 DF8[[[[ GCL\\\\

~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ DELTAMETHRIN 2.5%

~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~

EXP. DATE : June- 2019

Batch No: Quantity Packed:

Mfg. Date: _ Net Weight: _

Manufactured by: _

39 of 51


Gandhinagar.

ANNEXURE-VII

STATEMENT OF CAPACITY OF PRODUCTION

01. Name of firm :

Address :

Telephone /Fax /Mobile No. :

E-mail Address :

Name of responsible person to be contacted

02. The installed capacity of this firm is as follows:

Dry Tablets Vials

Capsules Bottles

Wet Internal

(liquids and colloids)

Syrups Ampoules

External

Liquids

Creams Drops/Ointments

Ointments

Signature of the bidder:

Full Name (IN BLOCK LETTERS)

Note:Details are to be provided for one month's production capacity.

Sr.

No.

Name of Certificate Particulars Validity

1. Gujarat Commercial Tax No.

2. Central Sales Tax No.

3. Drug Manufacturing License No.

4. Whole sale Drug License No.

5. WHO GMP No.

6. CSPO Reg. No.

7. Micro/small enterprise Reg. No. (As per old or new acknowledgement)

40 of 51


Gandhinagar.

ANNEXURE-VIII

(FORMAT OF AUTHORIZATION LETTER FOR AUTHORIZED DISTRIBUTOR)

{IN ORIGINAL}

(IN CASE OF IMPORTED ITEMS)

I / We hereby declare that....

1. M/s. is our

authorized distributor for our products in India from date and they are authorized to quote

and follow up on our behalf and the said agreement is valid in force as on date;

2. I/We undertake to supply the drugs / items for which the quotations of following items are submitted

by M/s. on our behalf in

respect of Tender Enquiry # :

Sr.No. Item No. Name of Item

(1)

(2)

3. I / We have read all the terms and conditions of the tender enquiry and the same are irrevocably

binding upon us till the expiry of the contract signed & executed on our behalf;

4. I/We shall notify the Managing Director,G.M.S.C.L. immediately if there is any change in the

agreement between M/s. and me/us regarding

authorized distributorship of our products and further undertake to supply the items quoted by the

distributor on my / our behalf at the quoted in the tender enquiry in case of such a change of

agreement.

5. This authority is applicable only for Tender Enquiry # .

Date:- Signature of Authorized Signatory

41 of 51


(A Government of Gujarat Undertaking) Gandhinagar.

ANNEXURE-IX

(REF.CLAUSE NO 24 )

{ FORMAT OF AFFIDAVIT OF DECLARATION ABOUT

DEBARMENT OF MANUFACTURER FOR THE ITEMS QUOTED}

{ON STAMP PAPER OF RS. 20.00 & TO BE NOTARIZED}

I age residing at

in capacity of M/s. hereby solemnly

affirm that………..

1. M/s. is not debarred or blacklisted by Gujarat Medical

Services Corporation Limited (GMSCL) or for Failure in supply of Quality drugs by any State/

Central Government / Undertaking / Organization for the items quoted at present to the due date of

Tender Enquiry #

2. I / We undertake responsibility to bring attention of The Managing Director, Gujarat Medical

Services Corporation Limited (GMSCL), Gujarat State Gandhinagar, if tenderer will be debarred /

blacklisted by Gujarat Medical Services Corporation Limited (GMSCL) or for Failure in supply of

Quality drugs in future by any State/ Central Government / Undertaking / Organization..

3. I / We state that I / We am/are observing all the conditions of the drug licenses and provision of the

drug & cosmetics ACT-1940 and rules there under meticulously. Further I / We undertake that I /

We shall remain scrupulous in observing the various provisions of the drug & cosmetics ACT- 1940,

Amendment there in and rules there under throughout the contract period.

DATE: {SIGNATURE & STAMP OF THE AUTHORIZED SIGNATORY}

{SIGNATURE & STAMP OF THE NOTARY}

42 of 51

ANNEXURE-X

CHECKLIST FOR TENER SUPPORTING DOCUMENTS

Sr. No Particulars GR

OUP

Date of

Issue Encircle

Yes/ No Remark

s 1 Copy of valid Drug Licence

& renewal of Drug Licence

(Manufacturing).

A

Yes/ No

2 Product permission A

Yes/ No

3 Import License (if applicable) A

Yes/ No

4 Affidavit of marketing Data

(As per format Annexure-II) B

Yes/ No

5 C.A. Certificate for Annual turnover of

firm A

Yes/ No

6 C.A. Certificate for showing year wise

Production & Turnover of quoted item . A

Yes/ No

7 WHOGMP Certificate A Yes/NA

8 Higher-Lower price certificate

(As per format Annexure-III) A

Yes/ No

9 PAN Card copy A Yes/ No

10 Non-conviction certificatefrom

F.D.C.A.(As per format Annexure-XII) A

Yes/ No

11 Performancecertificatefrom

F.D.C.A.(As per format nnexure-XI) A

Yes/ No

12 VAT Clearance Certificate (Last Financial Year) / Certified copy of VAT Return Mentioning Zero Outstanding (Last Financial Year).

A

Yes/ No

13 ISI Certificate A Yes

14 ISO Certificate A Yes/ No/NA

15 Micro/small enterprise Registration

certificat e in new acknowledgement. (As

per the Gazette of India Act-2006).

A

Yes/ No

16 CSPO / NSIC / DGS& D/ KVIC

registration certificate. A

Yes/ No

17 Affidavit of format of Certificates

(As per format Annexure-IV) B

Yes/ No

18 Authorization letter to a Senior

responsible Officer of the firm A

Yes/ No

19 Constitution of the firm (memorandum,

articles of association, partnership deed

etc.)

B

Yes/ No

20 Authorizationletterfor authorized

distributor.(In case of Imported Items)

(As per format Annexure-VIII)

Authorizationletterfor authorized

distributor.(In case of Imported Items)

(As per format Annexure-VIII)

A

Yes/ No

21 Undertaking&Verification of

Documents (As per format Annexure I)

(ON STAMP PAPER OF Rs.20.00 &

TO BE NOTARIZED)

B

Yes/ No

22 Statement of Capacity of

Production

(As per format Annexure VII)

A

Yes/ No

23 Undertaking from where the supplies is

made. (For Out statetenderer whose

supplies made from Gujarat Depot.)

A

Yes/ No

24 Valid wholesale Drug License. (For Out

statetenderer whose supplies made from

Gujarat Depot.)

A

Yes/ No

25 Goods and Service Tax (GST) or Gujarat

sales Tax (VAT) registration certificate

&clearance certificate. (For Out state

tenderer whoses supplies made from

Gujarat depot.)

A

Yes/ No

26 Affidavit of Declaration about debarment

of manufacturerfor the items quoted

(As per format Annexure-IX)

B

Yes/ No

27 Self Certified / notarized copy of latest

audited annual balance sheet and

information providing their Investment in

plant and machinery to prove their present

status as an SSI Unit of Gujarat State.

B

Yes/ No

28 FFS certificate from FDCA. A Yes/ No/NA

29. Self-attested copy of Certificate from

Practicing Chartered Accountant or

Practicing company Secretary that the

unit / bidder still continues to be Small

Scale, Tiny/ Cottage Industry

A

Yes/ No

30 E.M.D. B Yes/ No/NA

31 TENDER FEE B Yes/ No/NA

32 Sales Tax (VAT) / CST / Goods and

Service Tax (GST)registration copy

A Yes/ No

It is verified that all the certificates / permissions / documents are valid and current as on

date and have not been withdrawn / cancelled by the issuing authority. It is further verified that

the certificates are as per the format given by GMSCL/Concerned authority and it is clearly

and distinctly understood by me / us that the tender is liable to be rejected if on scrutiny of

these certificates it is found to be not as per the prescribed format of GMSCL

I/We further undertake to produce on demand the original certificate / permission /

document for verification at any stage during the processing of the tender.

{SIGNATURE & STAMP OF THE TENDERER)

Note: The documents are differentiated in 2 parts Group-A & Group-B. Documents

classified in Group-A should be submitted online only and Group-B should be submitted

physical only, otherwise tender will be rejected. All required documents not mentioned

above must be submitted physically only. Price Tender Form (General Terms & Conditions

copy) is not required to be submitted.

Date:

Place :

45 of 51


(A Government of Gujarat Undertaking) Gandhinagar.

ANNEXURE-XI

(FORMAT OF PERFORMANCE CERTIFICATES)

Name and Address of concern FDCA

PERFORMANCE CERTIFICATE

On the basis of record / Information available in this office, this is to certify that up to time

of writing of this certificate, the performance of M/s

holding drug manufacturing licenses No.

is satisfactory.

It is further certified that the conditions of the drug licenses and all the provisions of the

drug and cosmetics Act 1940 and rules there under being observed by M/s.

Meticulously.

Date: SIGNATURE & STAMP OF THE AUTHORISED SIGNATORY

(CONCERNED FDCA)

46 of 51

ANNEXURE-XII

(FORMAT OF NON-CONVICTION CERTIFICATES)

Name and Address of concern FDCA

NON-CONVICTION CERTIFICATE

On the basis of the record / Information available in this office, this is to certify that M/s

have been granted drug

manufacturing licenses in Form No. 25 bearing No. & Form No. 28 bearing

No. under the provision of drugs & Cosmetics Act-1940 and rules there

under and that the said manufacturer has not been convicted for violation of provision of drugs &

Cosmetics Act-1940 & Rules there under during the preceding years.

It is further certified that the conditions of the drug licenses and all the provisions of the

drug and cosmetics Act 1940 and rules there under being observed by M/s.

Meticulously.

Date: SIGNATURE & STAMP OF THE AUTHORISED SIGNATORY

(CONCERNED FDCA)

47 of 51

ANNEXURE-XIII

List of Miscellaneous items for SSI units for Turnover condition No-12Vii(B)

Sr No Item code Name of Item

1 3016 Black Disinfectant Fluid Grade III Liq 5 litre jar

2 3017 Bleaching Powder Grade II I.S.I.Mark 5kg Bag

3 3018 Bleaching Powder Grade II I.S.I.Mark 25kg Bag

4 3023

Chlorhexidine Gluconate Soln 4% w/v

5 3031 Lysol (Cresol with Soap Solution)

(Cresol 50% + Soap 50%)

6 3057 Gamma Benzene Hexachloride Lotion 1%

7 3060 Gention Violet Topical Soln.

8 3061 Glutaraldehyde Soln 2% w/v

9 3078 Liquid Antiseptic (1 Litre)

10 3099 Povidone Iodine Solution 7.5% 1 Litre Bottle

11 3100 Povidone Iodine Solution 5% 1 Litre Jar

12 3109 Sodium Hypochlorite Solution 5 Liter Jar

13 3173 Liniment of Turpentine (30ml bottle)

14 3175

Compound Benzoin Tincture 500 ml Bottle

15 4022 Plaster Of Paris Bandage (10cm x 2.7mtr)

16 4023 Plaster Of Paris Bandage (15cm x 2.7mtr)

48 of 51

Tender Enquiry No. GMSCL/D-629/RC/2018-2019

SCHEDULE TO STANDARD, COMPOSITION, PACKING, EMD, MINIMUM BATCH SIZE,

WHOGMP, PACKING PER CARTON, APPROX. TWO YEARS REQUIREMENT ETC.

Attached excel file named TEEXCEL629.pdf

49 of 51

BIDDING SCHEDULES

Document Fee

Furnish the Payment Details of Tender Document

Sr. No Description Supplier Response

1. Amount (Rs.)

2. Bank Name

3. DD No.

4. Branch Name

Payment made toward document fee will not be refunded

Non payment of the document fee will be make the supplier liable for disqualifications

Wrong/ Fraudulent data submission may lead to disqualification, please ensure that you

furnish correct data

EMD

Furnish the Payment Details of EMD

Sr. No Description SupplierResponse

1. Amount in Rs.

2. Bank Name

3. Branch Name

4. DD / Bank

GuaranteeNo.

5. Date of DD / BG

Payment should be made by DD / BG, DD should be payable at Gandhinagar at any schedule

bank

Payment should be made in favor of "Gujarat Medical Services Corporation" Gandhinagar,

Gujarat, India

Payment made towards EMD will not be refunded unless bid is accepted

Nonpayment of the EMD or in sufficient amount of EMD will be make the supplier liable for

disqualifications

Wrong/ Fraudulent data submission may lead to disqualification, please ensure that you

furnish correct data.

50 of 51

Technical Item

No.

Name of

Item

Specification Packing Mfg by / at Offer Brand Specify

Packing Remarks

Commercial

Item

No.

Name

of

Item

Specification Packing Rates without

applicable

GST

per Liter

GST if

applicable

(In %)

Total Rate with

applicable GST

(%)

Total

Rates

(inwo

rds)

Rema

rks

SGST CGST IGST Total

GST

Note:

(1) Rate should be quoted very carefully as per packing unit.

a) The above quoted rates are inclusive of GST, Packing, Forwarding and Insurance charges F.O.R.

Destination anywhere in Gujarat.

b) I/We hereby confirm that the items quoted above conform to the standards, composition and packing as

shown in the schedule.

c) If GST is not applicable or exempted then enter “0” and specify in remarks column “No Tax (for GST)”

or “Exempted (for GST)”.

51 of 51

1

ANNEXURE TO SCHEDULE

Specification

ITEM CODE: 3013 NAME OF ITEM: HbSAg – Rapid TestKitfordetection of Hepatitis B surface Antigen (HbSAg) in Plasma / Serum.

(i) Non “ELISA reader”based test, immune chromatographic method

(ii) Kit must bebased on detection of Hepatitis B surface antigen (HBsAg) in plasma&

serum.

(iii) Suitableforprocessing of even single sample.

(iv) Sensitivity and specificity should beasperWHO standards.

(v) Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.

(vi) Kit should be stored & transported at 2* to 8* C temperature.

(vii) Controls must be provided with test kit.

(viii) The kit should be supplied complete with necessary accessoriesrequiredfor the test.

(ix) Kit should be FDA / CE approved.

(x) Detailed literature regarding kit should be provided along with tender

2


Specification

ITEM CODE: 3138

NAME OF ITEM: HCV Elisa TestKit Hepatitis C virusantibody detection3rd Generation test

(ELISA)

1. Should detect antibodies against HCV in human serum orplasma by ELISA test method.

2. Kit should be “ELISA reader” based test.

3. Specificity &SensitivityasperWHO standards

4. Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.

5. Kit should be stored & transported at 2* to 8* C temperature

6. The kit should be supplied complete with necessary accessoriesrequiredfor the test.

7. Controls must be provided with test kit.

8. Kit should be FDA / CE approved

9. Detailed literature regarding kit should be provided along with tender

3


Specification

ITEM CODE: 3139 NAME OF ITEM: HCV Rapid TestKit Hepatitis C Virus 3rd Generation Test (Rapid)

(i) Should detect anti bodies against HCV in human serum or plasma.

(ii) Testkit should benon “ELISA reader”base/ immunochromatographic test.

(iii) Specificity &SensitivityasperWHO standards

(iv) Shelflifeperiod should beminimum 1 yearto the end user from the date of supply.

(v) Kit should be stored & transported at 2* to 8* C temperature

(vi) The kit should be supplied complete with necessary accessoriesrequiredfor the

test.

(vii) Controls must be provided with test kit.

(viii) Kit should be FDA / CE approved

(ix) Detailed literature regarding kit should be provided along with tender

4


Specification

ITEM CODE: 3143

NAME OF ITEM: PregnancyTestKit forHCG detection

1. A rapid immunochromatographicimmunoassay forqualitativedetection of human Chronic

Gonadotropin (HCG) in urine.

2. Should be able todetect presence of HCG in urine at sensitivity of 20 to 30 MIU/ml


4. Kit should be stored & transported at 2* to 8* C temperature



7. Kit should beISO approved

8. Detailed literature regarding kit should be provided along with tender

.

5


Specification

ITEM CODE: 3157

NAME OF ITEM: Serum RPRTestKit (RPR test)

1. Kit should becardiolipin antigen based RPRtest kit. Antigen should be carbon particle

coated with cardiolipin antigen.


3. Kit should be stored & transported at 2*C to 8* C temperature

4. Sensitivityshould beasperWHOstandards



7. Kit should be FDA / CE / ISO approved

8. Detailed literature regarding Kit should be provided along with tender.

6

ANNEXURETO SCHEDULE

Specification

ITEM CODE: 3158 NAME OF ITEM: Serum WidalTestKit (Rapid Slide Test)

1. Kit should have Stained salmonella antigens for "O", “H," Para-A, Para-B,


3. Kit should be stored & transported at 2*C to 8*C temperature



6. Kit should beISO approved

7. Detailed literature regarding Kit should be provided along with tender.

7

J

Sr.

No.

Item

CodeName of Item STD Composition Packing Unit

Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

1 1001Acetazolamide

Tablets 250mgIP

Each Tablet contains:

Acetazolamide IP 250mg

Box of 10x10 Tab. In

Blister with Alu.back ($)2 Years 100000 Yes

100

Box1153000 Tablet 28700

2 1005Acyclovir

Tablets 200mgIP


Aciclovir IP 200mg



100

Box3907000 Tablet 84400

3 1006Albendazole

Tablets 400mg IP

Each Chewable Tablet contains:

Albendazole IP 400mg


Blister with Alu.back2 Years 400000 Yes

20

Box114382000 Tablet 785700

4 1012Amitriptyline HCL

Tablets 25mgIP

Each Coated Tablet contains:

Amitryptiline Hydrochloride IP

25mg



200

Box10012000 Tablet 50300

5 1013Amlodipine

Tablets 5mgIP


Amlodipine Besylate IP eq.to

Amlodipine 5mg



50

Box67451000 Tablet 121400

6 1016Amoxycillin

Capsules 500mgIP

Each Capsule contains:

Amoxycillin Trihydrate IP eq.to

Amoxycillin 500mg

Box of 10x10 Cap. In

Alu.Foil Strip/Blister with

Alu.back ($)

2 Years 100000 Yes100

Box 132661000 Capsule 5153900

7 1017Amoxycillin

Capsules 250mgIP



Amoxycillin 250mg



Alu.back ($)

2 Years 400000 Yes100

Box92290000 Capsule 1911800

8 1018

Amoxycillin

Dispersible

Kid Tablets 125mg

IP

Each Dispersible Tablet contains:


125mg of Amoxycillin in

suitable dispersible base



Alu.back

2 Years 400000 Yes30

Box64842000 Tablet 756000

9 1021

Ascorbic Acid

Tablets 500mg

Chewable

---

Each Uncoated Tablet contains:

Ascorbic Acid IP 100mg,

Sodium Ascorbate IP 450mg

(eq. to 400mg of Ascorbic acid)



20

Box64418000 Tablet 910800

10 1023Atenolol Tablets

50mgIP


Atenolol IP 50mg


Blister with Alu.back 2 Years 400000 Yes 20 Box 131763000 Tablet 417900

Schedule to STANDARD, COMPOSITION, PACKING UNIT, EMD, MINIMUM BATCH SIZE, WHOGMP, PACKING PER CARTON, APPROX. REQUIREMENT

T.E.No.GMSCL/D-629/RC/2018-2019

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

11 1025

Benzhexol Tablets

(Trihexyphenidyl)

2mg

IPEach Tablet contains:

Benzhexol Hydrochloride IP 2mg


Blister with Alu.back2 Years 400000 Yes 50 Box 9294000 Tablet 20000

12 1026Bisacodyl Tablets

5mgIP

Each Enteric Coated Tablet contains:

Bisacodyl IP 5mg



13 1031Carbamazepine

Tablets 200mg IP


Carbamazepine IP 200mg



14 1034Cefadroxil Kid

Tablets 125mg---


Cefadroxil IP eq.to Anhydrous

Cefadroxil 125mg


Alu.Foil Strip/ Blister

with Alu.back

2 Years 400000 Yes 30 Box 35818000 Tablet 639400

15 1039Chloroquine Tablets

250mgIP


Chloroquine Phosphate IP 250mg


Blister Strip packing with

transparent top


16 1040Chloroquine Tablets

500mgIP


Chloroquine Phosphate IP 500mg


Blister Strip packing with

transparent top ($)

2 Years100000

Yes 20 Box 760000 Tablet 20300

17 1041Chlorpheniramine

Maleate Tablets 4mg IP


Chlorpheniramine Maleate IP 4mg



18 1051Clotrimazole Vaginal

Tablets 100mg IP

Each Vaginal Tablet contains:

Clotrimazole IP 100mg

Box of 25x6 Tab. In

Alu. Foil strip ($)2 Years 100000 Yes 50 Box 7073000 Tablet 151800

19 1059Dexamethasone

Tablets 0.5mgIP


Dexamethasone IP 0.5mg



20 1060Diazepam

Tablets 5mgIP


Diazepam IP 5 mg



21 1061Diclofenac Sodium

Tablets 50mg IP

Each Enteric coated Tablet contains:

Diclofenac Sodium IP 50 mg.



22 1062Dicyclomine

Tablets 20mgIP


Dicyclomine Hydrochloride IP 20mg



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

23 1063Diethylcarbamazine

Citrate Tablets 100mgIP


Diethylcarbamazine Citrate IP

100mg


Blister with Alu.back ($)2 Years 100000 Yes 200 Box 1672000 Tablet 7500

24 1064Digoxin Tablets

0.25mg IP


Digoxin IP 0.25mg


Aluminium Foil Strip ($)2 Years 200000 Yes 200 Box 2165000 Tablet 23300

25 1065Diloxanide Furoate

Tablets 500mgIP


Diloxanide Furoate IP 500mg



26 1068Domperidone

Tablets 10mgIP


Domperidone Maleate IP

eq.to Domperidone 10mg



27 1071Doxycycline

Capsules 100mg IP


Doxycycline Hydrochloride IP

eq.to Doxycycline 100mg


Blister with Alu.back ($)2 Years 400000 Yes 100 Box 156791000 Capsule 851300

28 1072 Enalapril Tablets 5mg IPEach Tablet contains:

Enalapril Maleate IP 5 mg



29 1075Eteophylline &

Theophylline Tablets---


(1) Eteophylline IP/BP 77mg

(2) Theophyline IP 23mg



30 1081Ferrous Sulphate

Tablets 200mgIP

Each Sugar coated Tablet contains:

Dried Ferrous Sulphate IP 200mg


Blister with Alu.back2 Years 400000 Yes 30 Box 68346000Tablet 154300

31 1083Fluoxetine

Capsules 20mg IP


Fluoxetine Hydrochloride IP

eq.to Fluoxetine 20 mg


Alu. Foil Strip ($)2 Years 200000 Yes 100 Box 7993000 Capsule 73100

32 1084

Folic Acid & Ferrous

Sulphate Tablets

(Small) IP

Each Enteric coated Tablet

contains:Exsiccated

Ferrous Sulphate IP 67mg eq.to

20mg of elimental Iron;

Folic Acid IP 0.1mg



33 1086Folic Acid

Tablets 5mg IP


Folic Acid IP 5mg



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

34 1087Frusemide

Tablets 40mgIP


Frusemide IP 40 mg



35 1093Haloperidol

Tablets 5mgIP


Haloperidol IP 5mg



36 1096Ibuprofen

Tablets 400mgIP


Ibuprofen IP 400mg



37 1100Isosorbide Dinitrate

Tablets 10mgIP

Each Sublingual Tablet contains:

Diluted Isosorbide Dinitrate IP

eq. to Isosorbide Dinitrate 10 mg



38 1107 Mefloquine

Tablet 250mgIP


Mefloquine Hydrochloride IP

eq. to Mefloquine 250mg


Aluminium Foil Strip/

Blister

with Alu.back


39 1108Metformin

Tablets 500mgIP


Metformin Hydrochloride IP 500 mg



40 1110Methyldopa

Tablets 250mg IP


Anhydrous Methyldopa IP 250mg



41 1112Metoclopramide

Tablets 10mgIP


Metoclopramide Hydrochloride IP

eq.

to Anhydrous Metoclopramide 10mg



42 1113Metronidazole

Tablets 400mgIP


Metronidazole IP 400mg



43 1114Metronidazole

Tablets 200mgIP


Metronidazole IP 200mg



44 1119Norethisterone

Tablets 5mg IP


Norethisterone IP 5mg


Alu. Foil Strip ($)2 Years 100000 Yes 100 Box 1920000 Tablet 42500

45 1120Norfloxacin Kid

Tablets 100mg ---


Norfloxacin IP 100mg



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

46 1121Norfloxacin

Tablets 400mgIP


Norfloxacin IP 400mg


Alu. Foil Strip/ Blister

with Alu.back


47 1124Ofloxacin

Tablets 200mgIP


Ofloxacin (Calculated on Dried

basis) IP 200 mg



48 1127Paracetamol

Tablets 500mg IP


Paracetamol IP 500mg



49 1134Prednisolone

Tablets 5mgIP


Prednisolone IP 5mg



50 1135Primaquine

Tablets 2.5mgIP


Primaquine Phosphate IP

eq.to Primaquine 2.5mg



51 1148Quinine Tablets

300mgIP


Quinine sulphate IP 300mg



52 1149Quinine Tablets

100mgIP


Quinine sulphate IP 100mg



53 1152Risperidone Tablets

2mgUSP


Risperidone USP 2mg



54 1154Salbutamol Tablets

4mg IP


Salbutamol Sulphate IP

eq.to Salbutamol 4mg



55 1155Sodium Valproate

Tablets 200mgIP


Sodium Valproate IP 200 mg


Alu.Foil Strip2 Years 400000 Yes 20 Box 58442000 Tablet 1034400

56 1156Sodium Valproate

Tablets 500mgIP


Sodium Valproate IP 500 mg


Alu.Foil Strip ($)2 Years 100000 Yes 50 Box 5930000 Tablet 249100

57 1158Spironolactone

Tablets 25mgIP


Spironolactone IP 25 mg



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

58 1167TrifluoperazineHCL

Tablets 5mgIP


Trifluoperazine Hydrochloride IP 5

mg


Alu. Foil Strip ($)2 Years 200000 Yes 100 Box 2855000 Tablet 18100

59 1168

Trimethoprim &

Sulphamethoxazole

(clotrimazole tablet)

Tab 480mg

IP


(1)Trimethoprim IP 80mg &

(2) Sulphamethoxazole IP 400mg



60 1171Vitamin A Capsules

50,000 IU

IP/

USP

Each Soft Gelatin Capsule contains:

Vitamin A USP/IP 50000 IU



61 1172Vitamin A Capsules

2,00,000 IU

IP/

BP/

USP

Each Soft Gelatin Capsule contains:

Vitamin A USP/BP/IP 200000 IU



62 1173 Vitamin B Complex

Tablets (Therapeutic)---


Thiamine Hydrochloride IP 5mg;

Riboflavine IP 5mg; Pyridoxine

Hydrochloride IP 2mg; Niacinamide

IP 50mg; Calcium Pantothenate IP

5mg

Product Permission as NFI or NFI

Formula will be eligible subject to

above composition only.


Aluminium Foil Strip 2 Years 400000 Yes 20 Box 377147000 Tablet 2181100

63 1178Fluconazole

Tablets 50mgIP


Fluconazole IP 50mg

Box of 10x10 Tablet In


64 1182Salbutamol Rotacaps

200mcg---

Each Rotacap contains:

Salbutamol Sulphate IP eq.to

Salbutamol 200mcg

Box of 10x30 Rotacaps

with Rotahaler ($)2 Years 100000 Yes 20 Box 2022000 Rotacap 32600

65 1185Azithromycin Tablets

500mgIP


Azithromycin IP 500mg



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

66 1198Atorvastatine Tablets

10 mgIP


Atorvastatine Calcium eq. to

Atorvastatine IP 10mg


Alu. foil strip2 Years 400000 Yes 100 Box 71108000 Tablet 458600

67 1199Cefixime Tablet

200mgIP

Each Film Coated Tablet contains:

Cefixime IP as Trihydrate eq. to

Anhydrous Cefixime 200 mg


Blister with Alu.back($)2 Years 400000 Yes 100 Box 62428000 Tablet 3848600

68 1200Diclofenec Sodium

Suppository 12.5mg---

Each Suppository contains:

Diclofenec Sodium IP 12.5mg.,

Suppository base q.s.

Box of 20x5

Suppositories

In Blister with Alu.back

($)

2 Years 100000 Yes 100 Box 294000 Suppository 27300

69 1202EsCitalopram Oxalate

Tablets 10mgIP


EsCitalopram Oxalate IP

eq.to EsCitalopram 10mg



70 1203Lorazepam

Tablet 2mg

BP/

USP


Lorazepam BP/USP 2mg



71 1204Metoprolol

Tablets 25mgIP


Metoprolol Tartrate IP 25mg



72 1205Olanzapine

Tablet 5mgIP


Olanzapine IP 5mg



73 1208Misoprostol

Tablet 200mcg---


Misoprostol 200mcg.

Box of 25x4 Tablets In

Blister with Alu.back ($) 2 Years 100000 Yes 100 Box 2862000 Tablet 106300

74 1213Paracetamol Kid

Tablets 125mg---


Paracetamol IP 125mg.



75 1214Aceclofenac

Tablets 100mgIP


Aceclofenac IP 100mg.



76 1218Levofloxacin

Tablets 500mgIP


Levofloxacin Hemihydrate IP

eq. to Levofloxacin 500mg.


Blister with Alu.back ($) 2 Years 100000 Yes 100 Box 17178000Tablet 786500

77 1221Losartan Potassium

Tablets 50mgIP


Losartan Potassium IP 50mg.



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

78 1224Pantoprazole

Tablets 40mgIP


Pantoprazole Sodium Sesquihydrate

eq.to Pantoprazole 40mg.



79 1226Glimepiride Tablets

1mgIP


Glimepiride IP 1 mg



80 1230Artemether &

Lumefantrine Tablets ---

Each Tablet contains: Artemether

IP 80mg, Lumefantrine 480mg

Box of 5x6 Tab. In


81 1240 Spironolactone

Tablets 100mg IP


Spironolactone IP 100mg



82 1242Clopidogrel

Tablets 75mgIP


Clopidogrel IP 75mg


Alu. foil strip ($) 2 Years 200000 Yes 100 Box 8480000 Tablet 158000

83 1243Levothyroxine

Tablets 50mcg IP

Each Scored Tablet contains:

Anhydrous Levothyroxine IP 50mcg



84 1244Levothyroxine

Tablets 100mcg IP

Each Scored Tablet contains:

Anhydrous Levothyroxine IP 100mcg



85 1249Tramadol

Capsules 50mgIP


Tramadol HCL IP 50mg.


Blister with Alu.back ($) 2 Years 200000 Yes 100 Box 8206000 Capsule 82200

86 1250Tramadol

Capsules 100mgIP


Tramadol HCL IP 100mg.


Blister with Alu.back ($) 2 Years 200000 Yes 100 Box 3025000 Capsule 33600

87 1251

Zinc Sulphate

Dispersible

Tablets 20mg

---


Zinc Sulphate Monohydrate eq. to

20 mg of elemental Zinc (Note: Add

sufficient sweetening & flavouring

agents

& Tablet should be score)



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

88 1253Deferasirox Tablets

250mg---

Each Tablet for oral suspension

contains: Deferasirox 250mg

Bottle of 30 Tab./

Strip of 3x10

Tab.(30Tab.)

2 Years 100000 Yes100

Bottle740000 Tablet 277500

89 1254Deferasirox Tablets

500mg---

Each Tablet for oral suspension

contains: Deferasirox 500mg

Bottle of 30 Tab./

Strip of 3x10

Tab.(30Tab.)

2 Years 100000 Yes100

Bottle2230000 Tablet 1137300

90 1257Atorvastatin

Tablets 40mgIP

Each Tablet contains: Atrovastotin

calcium eq. to Atorvastatin IP 40mg.


Alu. Foil ($)2 Years 100000 Yes 100 Box 17567000 Tablet 410500

91 1258Bisacodyl

Suppository IP


Bisacodyl IP 5mg Suppository base

q.s.

Box of 20x5

Suppositories


($)

2 Years 50000 Yes 100 Box 261000 Suppository 37600

92 1260Diclofenac Sodium

Suppository 50mg---


Diclofenac Sodium IP 50 mg,

Suppository base q.s

Box of 20x5

Suppositories


($)

2 Years100000

Yes 100 Box 280000 Suppository 27600

93 1262

Iron and Folic acid

tablet

Blue IFA (Large)-

WIFS

IP

Each Enteric Coated Blue coloured

(Indigo Carmine) Tablet contains:

Dried Ferrous Sulphate IP eq.to

Ferrous Iron 100mg &

Folic Acid IP 0.5mg


Blister with Alu.back2 Years

400000 Yes 20 Box 487906000 Tablet 1805300

94 1268Oseltamivir Capsule

75mg IP


Oseltamivir Phosphate IP 75mg


Alu. Foil Strip/Blister

with

Alu.back($)

2 Years 100000 Yes 100 Box 3590000 Capsule 2328100

95 1266 Acetyl Salicylic Acid

Tablet 350mg

IP/BP

/

USP


Acetyl Salicylic Acid IP 350mg


Aluminium Foil Strip ($) 2 Years 200000 Yes 100 Box 1214000 Tablet 10600

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

96 1269Nifedipine Sustain

Release Tablet 10mgIP

Each Sustained Release Film Coated

Tablet contains: Nifedipine IP 10mg.



97 1270Carvedilol

Tablet 12.5mgIP


Carvedilol 12.5mg


Alu. Foils Strip ($) 2 Years 100000 Yes 100 Box 1162000 Tablet 32700

98 1271Fluconazole

Tablet 150mgIP


Fluconazole IP 150mg



99 1272Cefadroxil

Tablet 500mgIP


Cefadroxil IP eq.to 500 mg

of Anhydrous Cefadroxil



100 1273Iron Folic Acid (IFA)

Tablet (Small)pink IP


Elementary Iron IP 45mg and

Folic acid IP 400 mcg.



101 1276Famotidine Tablets

40mgIP


Famotidine IP 40mg



102 1277Famotidine Tablets

20mgIP


Famotidine IP 20mg



103 1300Clobazam Capsule

5mg

IP/

BP/

USP


Clobazam IP 5mg



with Alu.back ($)


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

104 1307

Kit3/ White Clr

Benzathine Penicillin

Inj

& Azithromycin Tab

---

Kit3/ White Colour Each Kit

Containing 1 Vial Injection of

Benzathine Penicillin (2.4MU) &

Strip of 1 Tablet of

Azithromycin IP 1 gm.

Each Kit Containing

Injection Benzathine

Penicillin (2.4MU) 1 Vial

+

Strip of Tablet

Azithromycin

IP 1 gm OD. Such 10 Kits

should be Packed in a

Box.

2 Years --- Yes ---- 124000 Tablet 1000


30mgIP


Oseltamivir Phosphate IP 30mg.



with

Alu.back($)


106 1321Tab. Aripiprazole

15mg

IP/BP

/

EUP/

USP


Aripiprazole 15 mg.


Aluminium Foil

Strip/Blister

with Alu.back ($)


107 1326

Tab. Methyl

Phenidate

10mg

---


Methyl Phenidate Hydrochloride 10

mg


Aluminium Foil

Strip/Blister

with Alu.back ($)


108 1328Tab. Atomoxetine

18mg

IP/BP

/

EUP/

USP


Atomoxetine 18 mg


Aluminium Foil

Strip/Blister

with Alu.back ($)


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

109 1336Cap. Atazanavir

300mg---


Atazanavir IP 300 mg.

Bottle of 30 Tablet duly

sealed with plastic plug/

diagram and should

contain

silicon packs.tightly

fitting

suitable screw cap.

2 Years --- Yes --- as may be required 1000

110 1340

Tab. ZL Baby

(Zidovudine 60mg +

Lamivudine 30mg)

---


Zidovudine IP 60mg and

Lamivudine IP 30mg.



diagram and should

contain


fitting

suitable screw cap.


111 1342Tab. Nevirapine

50mg IP


Nevirapine IP 50mg.



diagram and should

contain


fitting

suitable screw cap.


112 1343Tab. Lopinavir 100mg

& Ritonavir 25mgIP


Lopinavir IP 100mg &

Ritonavir IP 25mg.



diagram and should

contain


fitting

suitable screw cap.


113 1344

Abamune L Baby

(Abacavir 60mg &

Lamivudine 30mg)

---

Each Film Coated Tablet contain:

Abacavir IP 60mg and

Lamivudine IP 30 mg



diagram and should

contain


fitting

suitable screw cap.


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

114 1352Tab.Nitazoxanide

500mg---

Each Tablet contain:

Nitazoxanide 500 mg


Aluminium Foil

Strip/Blister

with Alu.back ($)


115 1357

Levothyroxine

Tablets

25mcg

IPEach Scored Tablet contains:

Anhydrous Levothyroxine IP 25 mcg


Blister with Alu back ($)2 Years --- Yes --- 113000 Tablet 1000

116 1358Labetalol Tablet

50mg


Labetalol 50 mg


Blister with Alu back ($).2 Years

200000 Yes 100 Box 234000 Tablet 1000


45mgIP


Oseltamivir Phosphate IP 45 mg.



with

Alu.back($)


118 2003

Amikacin Sulphate

Injection 500 mg

(For IM/IV Use)

IP

Each 2ml contains:

Amikacin Sulphate IP

eq.to Amikacin 500mg

Box of 10x2ml Vial 2 Years 10000 Yes 100 Box 3092000 Vial 853400

119 2004

Amikacin Sulphate

Injection 100 mg

(For IM/IV Use)

IP

Each 2ml contains:

Amikacin Sulphate IP

eq.to Amikacin 100mg


120 2005

Aminophylline

Injection

2.5% w/v

(For IV Use)

IP

Each 10 ml contains:

Equal amount of Anhydrous

Aminophylline IP 250mg

Box of 25x10ml Amp 2 Years 3000 Yes 30 Box 207000 Amp 18800

121 2007

Amoxycillin &

Clavulanic

Acid Injection 300mg

IP

Each Vial contains:

Amoxycillin Sodium IP

eq.to Amoxycillin 250mg &

Clavulanate Potassium IP

eq.to Clavulanic Acid 50mg

Box of 10 Vial 2 Years 3000 Yes 50 Box 233000 Vial 80200

122 2010

Ampicillin Sodium

Injection 500 mg

(IM/Slow IV Use)

IP

Each Vial contains:

Ampicillin Sodium IP

eq.to Ampicillin 500mg


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

123 2012

Anti-D (RHO)

Immunoglobulin

(Human)

Injection 300mcg

(liquid)

IP/BP

/

USP/

EUP

Each Vial contains:

Anti-D (RHO) Immunoglobulin

(Human) 300 mcg

One Vial Individually

Packed2 Years 300 Yes 100 Box 24000 Vial 1503400

124 2013Artemether Injection

80mg---

Each ml contains:

Artemether 80 mgBox of 10x1ml Amp 2 Years 2000 Yes 100 Box 22000 Amp 11400

125 2014

Atracurium Besilate

Injection 10 mg/ml

(For IV/Infusion Use)

IP/

USP/

BP

Each ml contains:

Anhydrous Atracurium

Besilate 10mg

Box of 5x2.5ml Amp 2 Years 5000 Yes 200 Box 232000 Amp 139400

126 2015Atropine Sulphate Inj.

(for IM/IV use)IP

Each ml contains:

Atropine Sulphate IP 0.6mgBox of 25x1ml Amp 2 Years 10000 Yes 100 Box 1776000 Amp 74000

127 2019Bupivacaine HCL

Injection (20ml Vial)IP

Each ml contains:

Anhydrous Bupivacaine

Hydrochloride IP 0.5% w/v


128 2023

Cefazoline Sodium

Injection 500 mg

(For IM/IV/Infusion)

IP

Each vial contains:

Cefazoline Sodium IP

eq.to 500mg of Cefazoline


129 2027

Ceftazidime for

Injection 1 gm

(For Deep IM/Slow

IV Infusion)

IP

Each vial contains:

Ceftazidime (Pentahydrate) IP

eq.to 1gm of Ceftazidime

Sodium; Carbonate or Argenine q.s.


130 2029

Ceftriaxone for

Injection 500 mg

(For Deep IM/Slow

IV Infusion)

IP

Each vial contains:

Ceftriaxone Sodium IP

eq.to Anhydrous Ceftriaxone 500mg


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

131 2031

Chloroquine

Phosphate

Injection 40 mg/ml

(For IM/Slow IV Use)

IP

Each ml contains:

Chloroquine Phosphate IP

eq.to Chloroquine 40mg


132 2032

Pheniramine Maleate

Injection

(For IM/IV Use)

IP

Each ml contains:

Pheniramine Maleate IP 22.75 mg,

Water for Injection IP q.s


133 2039

Dexamethasone

Sodium

Injection (For IM/IV

Use)

IP

Each ml contains:

Dexamethasone Sodium Phosphate

IP

eq.to Dexamethasone Phosphate 4mg


134 2046

Diatrizoate

Maglum.& Diat.

Sod.Inj. 60%

IP/

BP/

USP/

EUP

Each ml contains:

(i) Sodium Diatrizoate 80mg

(ii) Meglumine Diatrizoate 520mg

(Total Iodine Conc.292mg/ml

i.e.60%)


135 2047

Diatrizoate

Maglum.& Diat.

Sod.Inj. 76%

IP/

BP/

USP/

EUP

Each ml contains:

(i) Sodium Diatrizoate USP 100mg

(ii) Maglumine Diatrizoate USP

660mg

(Total Iodine conc.370mg/ml

i.e.76%)


136 2048

Diazepam Injection

5 mg/ml (For IM/IV

Use)

IPEach ml contains:

Diazepam IP 5mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 765000 Amp 62800

137 2049

Diclofenac Sodium

Injection 25 mg/ml

(For IM Use)

IPEach ml contains:

Diclofenac Sodium IP 25mgBox of 25x3ml Amp 2 Years 10000 Yes 100 Box 9804000 Amp 423500

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

138 2050

Dicyclomine HCL

Injection 20 mg/2 ml

(For Deep IM Use)

IP/BP

/

USP/

EUP

Each ml contains:

Dicyclomine Hydrochloride 10mg

(Isotonic solution)


139 2056

Dobutamine

Hydrochloride

Injection 50 mg/ml

(For IV Infusion)

USP

Each ml contains:

Dobutamine Hydrochloride USP

eq.to Dobutamine 50mg


140 2057

Dopamine

Hydrochloride

Injection 40 mg/ml

USPEach ml contains:

Dopamine Hydrochloride USP 40mgBox of 5x5ml Amp 2 Years 3000 Yes 200 Box 355000 Amp 76400

141 2059

Eteophylline &

Theophylline

Injection

----

Each 2 ml contains:

Etophylline IP 85/ BP 169.40mg

Theophylline IP 50.60 mg


142 2061

Fentanyl Citrate

Injection

(For

IM/IV/Transdermal

Use)

IP

Each ml contains:

Fentanyl citrate IP eq.to

50 mcg of Fentanyl

Box of 10x2ml Amp 2 Years 10000 Yes 100 Box as may be required 1000

143 2065Frusemide Injection

For (IM/slow IV use)IP

Each ml contains:

Frusemide IP 10 mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 1666000 Amp 90000

144 2073

Haloperidol

Injection

(For IM/IV Use)

IP

Each ml contains: Haloperidol IP 5

mg

(It is a sterile solution of Haloperidol

in

lactic acid diluted with Water For

Inj.)


145 2074Heparin Injection (For

IV/SC Use)IP

Each ml contains: Heparin Sodium

IP

eq.to Heparin 5000 units


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

146 2075

Hepatitis B Vaccine

10mcg/0.5 ml (1ml

Amp)

IP

Mfgd. by Recombinant DNA

Technology Strength of

Vaccine 20mcg/ml

1 ml Amp/Vial

Individually packed2 Years 1000 Yes

200

Amp/Via

l

35000 Amp/Vial 38900

147 2076

Hepatitis B Vaccine

10mcg/0.5ml (10ml

Vial)

IP

Mfgd. by Recombinant DNA

Technology Strength of

Vaccine 20mcg/ml

10ml Vial Individually

packed2 Years 1000 Yes 200 Vial 3000 Vial 18600

148 2079

Hydrocortisone

Sod.Succinate Inj

100mg

IP

Each vial contains: Hydrocortisone

Sodium Succinate IP eq.to

Hydrocortisone 100mg


149 2088

Ketamine

Hydrochloride

Injection 50mg

(Deep IM/slow IV

use)

IP

Each ml contains:

Ketamine Hydrochloride IP eq.to

Ketamine 50 mg


150 2090

Lignocaine &

Adrenaline

Injection 30ml Vial

IP

Each ml contains: (i) Lignocaine

Hydrochloride IP 20mg; (ii)

Adrenaline

bitartrate IP eq.to Adrenaline

0.01mg.

Box of 10x30ml Vial 2 Years 5,000.00 Yes 20 Box 96000 Vial 25900

151 2097

Lyophilised

Antisnake

Venom Serum

(snake venom

antiserum Powder)

IP

Powder eq.to 10 ml of purified &

conc.globulin from serum of horses

immunised against four poisonous

snakes of India.

10 ml Vial Individually

packed2 Years 1000 Yes 100 Vial 148000 Vial 2220000

152 2107 Inj. Mephenteramine

15mg/ml IP

Each ml contains:

Mephentermine Sulphate IP 15mgBox of 25x1ml Amp 2 Years 10000 Yes 100 Box 97000 Amp 12100

153 2108

Methotrexate

Injection

50mg/2ml

IPEach ml contains:

Methotrexate IP 25mg

2ml Vial Individually

packed2 Years 10000 Yes 100 Vial as may be required 1000

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

154 2109

Methyl Ergometrine

Maleate Inj (For

SC/IM/IV Use)

IP

Each ml contains:

Methyl Ergometrine Maleate IP 0.2

mg

Box of 25x1ml ambour

coloured glass Amp2 Years 10000 Yes 100 Box 400000 Amp 38400

155 2111

Metoclopramide

Hydrochloride

Injection (For IM/IV

Use)

IP

Each 2 ml contains: Anhydrous

Metoclopramide Hydrochloride IP

10mg


156 2117Inj. Gas Gangrene

AntitoxineIP

Each vial contains: Clostridium

Perfrigens antitoxin 10,000 IU,

Clostridium Oedematiens antitoxin

10,000 IU, Clostridium Septicum

antitoxin 5,000 IU.


Packed2 Years 400 Yes 100 Vial 4000 Vial 108000

157 2122

Neostigmine

Methylsulphate Inj

(For SC/IM/IV Use)IP

Each ml contains:

Neostigmine Methylsulphate IP

0.5mg


158 2128Paracetamol Injection

150mg/ml---

Each ml contains:

Paracetamol IP 150 mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 3217000 Amp 277900

159 2129

Pentazocine Injection

(For SC/IM/SLOW

IV Use)

IP

Each ml contains: Pentazocine

Lactate

IP eq.to Pentazocine 30 mg


160 2135

Pralidoxime Chloride

Injection (For

IM/SLOW IV

infusion Use)

IPEach vial contains:

Pralidoxime Chloride IP 1 gm

One Unit Individually

packed with Drug Vial &

20ml Amp of Sterile WFI

IP


Unit165000 Vial 331700

161 2138Promethazine HCL

InjectionIP

Each ml contains: Promethazine

Hydrochloride IP 25mgBox of 25x2ml Amp 2 Years 10000 Yes 100 Box 457000 Amp 21100

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

162 2141

Quinine

Dihydrochloride

(For SLOW IV Use)

IPEach ml contains: Quinine

Dihydrochloride IP 300mg.Box of 25x2ml Amp 2 Years 5000 Yes 100 Box 19000 Amp 7800

163 2143Ranitidine Injection

50mg/2mlIP

Each ml contains: Ranitidine

Hydrochloride IP eq.to Ranitidine

25mg


164 2145

Sodium Bicarbonate

Injection (For IV

infusion Use)

IPSodium Bicarbonate IP 7.5% (To be

used directly or diluted before use)Box of 25x10ml Amp 2 Years 5000 Yes 30 Box 331000 Amp 29400

165 2151

Sterile Vancomycin

Hydrochloride

Injection (For SLOW

IV Use)

IP

Each vial contains: Vancomycin

Hydrochloride IP eq.to

Vancomycin 0.5 gm.



166 2153

Sterile Water for

Injection

(5ml)

IPEach Amp.Contain Sterile Water For

Injection 5 mlBox of 25x5ml Amp 2 Years 10000 Yes 50 Box 6156000 Amp 249300

167 2160

Immunoglob. T.T.

Human

Injection 250 IU

IP/BP

/

USP/

EUP

Tetanus Immunoglobulin has a

potency

of not less than 100 IU of Tetanus

Antitoxin per ml

One Vial/Amp containing

250 IU Individually

packed

2 Years 500 Yes

100

Vial/Am

p

15000 Amp/Vial 364500

168 2162

Tetanus Vccine

(Adsorbed) human

(For deep IM

Use)Injection

IP

Each 0.5ml Amp /Vial contains:

Tetanus toxoid not less than 5 Lf

and not more than 25 Lf

Box of 10x0.5ml

Amp/Vial2 Years 10000 Yes 100 Box 2516000 Amp/Vial 634000

169 2164

Thiopentone Sodium

Injection

500mg (For IV Use)

IPEach Vial contains:

Thiopentone Sodium IP 0.5 gmBox of 10 Vial 2 Years 5000 Yes 50 Box 73000 Vial 41600

170 2168Vacuronium Bromide

Injection (for I.V. use)---

Each Vial/Amp contains:

Dried Vacuronium Bromide USP 4

mg

Box of 10 Amp/Vial

Individually packed2 Years 2000 Yes 100 Box 146000 Amp/Vial 83600

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

171 2173

Vitamin B Complex

Injection (For IM

Use)

---

Each ml contains: Vit.B1 IP10mg;Vit.B2

IP 2mg; Vit.B6 IP 2mg; Niacinamide IP

100mg; Di-panthenol 5mg


172 2186Multivitamin

Injection (IV Use)---

Each ml contains: Vitamin A (as

Palmitate) IP 1000 IU; Cholcelciferol

(Vit. D3) IP 100 IU; Alphatocophen

phenyl acetate IP 0.5mg; Ascorbic

acid IP 50mg; Thiamin HCL 5mg;

Ribofulvin Phosphate sodium IP

1.4mg;

Nicotinamide IP 10mg; Pyridoxin

HCL

IP 1.5mg; D-Penthonol USP 2.5mg;

Water For Inj. IP q s

Box 25x10ml Amp 2 Years 5000 Yes 30 Box 1685000 Amp 293200

173 2190

Vitamin B12

Injection(Cyanocobal

amin Injection)

IPEach ml contains:

Cyanocobalamin IP 500mcg.Box of 25x1ml Amp 2 Years 10000 Yes 100 Box 903000 Amp 61000

174 2195

Glycopyrrolate

Injection

(For IM/IV Use)

USPEach ml contains:

Glycopyrrolate USP 0.2mgBox of 25x1ml Amp 2 Years 3000 Yes 100 Box 527000 Amp 71700

175 2197Iohexol Injection (For

I.V.use)USP

Each ml contains: Iohexol USP

755mg

eq. to Iodine 350mg

50ml Vial/Bottle

Individually packed2 Years 1000 Yes

100

Vial/Bott

le

12000 Bottle 130100

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

176 2198

Methyl Prednisolone

Sodium Succinate for

Injection

(Powder)(For Slow IV

Infusion)

USP

Each vial contains: Methyl

Prednisolone

Sodium Succinate USP 500mg



177 2203

Sodium Chloride

Injection 100 ml

(For.I.V. use)

IPcontains:

Sodium chloride IP 0.9% w/v

100ml FFS Bottle packed

inpoly bag.(FFS Means

Plastic Bottle Mfg.Under

Form Fill & Seal

Technology

in Aseptic Environment)

2 Years 5000 Yes100

Bottle3988000 Bottle 801600

178 2213

Meropenem

Injections

500mg.(Powder form

reconstitution &

I.V.use only)

IP

Each Vial contain:

Meropenem trihydrate IP/USP

eq. to Anhydrus Meropenem 500mg.



179 2214

Levofloxacin

Injection

(500mg/100ml) For

I.V. use.

IP

Each 100ml contains:

Levofloxacin Hemihydrate IP eq. to

Levofloxacin 500mg,

Dextrose IP(Anhydrous) 5%w/v,

Water For Injection IP q.s.




Form Fill & Seal

Technology


2 Years 5000 Yes100


180 2215Aciclovir Injections

250mg (Dry Powder)IP

Each Vial contain:

Aciclovir (as sodium) IP 250mg.Box of 10 Vial 2 Years 2500 Yes 100 Box 151000 Vial 73400

181 2217

Fat Emulsion

Injections

20% w/v (PL/TG

Ratio 0.06) 250ml

---

Intravenous 20% Fat Emulsion with

size of the particles same as that of

Chylomicrons

250ml Glass/Plastic

Bottle

with Pharmacopoeial

quality

2 Years 1000 Yes 50 Bottle 12000 Bottle 79200

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

182 2219Amino Acid 10%

Injection ---

Intravenous 10% Amino Acid

Solution

Unique combination of all Essential,

Non Essential & Semi Essential

Amino Acids.

500ml Glass/Plastic

Bottle

with Pharmacopoeial

quality


183 2227Enoxaparin Sodium

Injection 60mg/0.6ml

IP/BP

/

USP/

EUP

Each Pre-filled syringe contains:

Enoxaparin sodium ph. Eur. 60mg

Water for Injection I.P. q.s. to 0.6ml

One Pre-filled syringe

Individually packed 2 Years 500 Yes

100

Pre-filled

syringe

223000 Pre-filled

syringe682400

184 2228Iron Sucrose Injection

(For I.V. use)

IP/BP

/

USP/

EUP

Each 5 ml Amp contains: Elemental

Iron (as Iron sucrose) 100mg,

Water For Injection q.s.

Pack of 5x5ml Amp 2 Years 1000 Yes 100 Pack 2492000 Amp 875200

185 2229

Sulbactum &

Cefoperazone

for Injection 1gm

---

Each Vial contains: Sulbactum

sodium

USP eq.to sulbactum 0.5gm,

Cefoperazone sodium IP eq.to

Cefoperazone 0.5 gm



186 2242Tramadol Injection

50mg/ml---

Each ml contains:

Tramadol IP 50mg. Box of 25x2ml Amp 2 Years 5000 Yes 100 Box 2435000 Amp 116800

187 2248

Atropine Sulphate

Injection (For

IM/IV Use)

IPEach ml contains:

Atropine Sulphate IP 0.6mg

30 ml vial

Individually Pack ($$).2 Years 3000 Yes 200 Vial 53000 Vial 55700

188 2250

Cisplatin Injection 10

mg

(Intravenous Infusion)

IP/BP

/

USP/

EUP

Each vial contains:

Cisplatin 10 mg

1 unit individually

pack.($$)2 Years 2000 Yes 500 Vial 4000 Vial 5900

189 2251

Cisplatin Injection 50

mg

(Intravenous Infusion)

IP/BP

/

USP/

EUP

Each vial contains:

Cisplatin 50 mg

1 unit individually

pack.($$)2 Years 1000 Yes 500 Vial 13000 Vial 73700

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

190 2254

Hydroxyethyl Starch

6%w/v (Intravenous

Infusion)

---

Each 100ml contains: Hydroxyethyl

starch 6gm, Sodium Chloride 900mg;

Electrolytes (mEq/L): Sodium 154,

Chloride 154; Osmolarity(calculated)

308-309 mOsmol/L; WFI q.s.




Form Fill & Seal

Technology


2 Years 2000 Yes 25

Bottle 22000 Bottle 107400

191 2255

Phytomenadione

(Vit.K1)

Inj. (For SC

/IM/SLOW IV Use)

IP/BP

/

USP/

EUP

Each ml contains:

Phytomenadione IP/BP/USP/EUP

1mg

Box of 10x0.5ml Amp 2 Years 10000 Yes 100 Box 740000 Amp 199000

192 2258

Bupivacaine

Hydrochloride

Injection (Heavy)

(For Spinal

anaesthesia)

USP

Each ml contains: Anhydrous

Bupivacaine Hydrochloride IP

0.5%w/v

& Dextrose Monohydrate IP 80mg


193 2271Filgrastim 300mcg

Injection---

Each vial contains:

Filgrastim 300mcg



194 2275Valethamate Bromide

Injection---

Each Amp Contains:

Valethamate Bromide 8 mgBox of 25x1ml Amp 2 Years 10000 Yes 200 Box 266000 Amp 23900

195 2290Lorazepam Inj. (for

IM/IU use)USP

Each ml contains:

Lorazepam USP 1 mg.Box of 10x2ml Vial/Amp 2 Years 2000 Yes 50 Box 116000 Amp/Vial 9700

196 2291Olanzapine Inj.

(for IM use) ---

Each vial contains:

Olanzapin 10 mgBox of 10 Vial 2 Years 2000 Yes 50 Box 10000 Vial 1000

197 2292Flupenthixol depot Inj

(For deep Im use) ---

Each ml contains:

Flupenthoixol depot 20mgBox of 10x1 ml Amp 2 Years 2000 Yes 50 Box 9000 Amp 56200

198 2293

Zuclopenthixol

Decanoate

Injection 200 mg

IP/BP

/

EUP/

USP

Each ml contain:

Zuclopenthixol decanoate

200 mg

Box of 10X1 ml Amp 2 Years 1000 Yes 50 Box 8000 Amp 38400

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

199 2294

Desferrioxamine

Mesylate

Injection 500mg

IP

Each vial contains:

Desferrioxamine Mesylate IP

500mg for injection


200 2300Ulinastatin Injection

1,00,000 IUANY

Each vial contains:

Ulinastatin 100000 IU.



201 2303Nadroparin Injection

0.6ml ---

Each 0.6 ml vial contains:

Nadroparin Injection 0.6 ml



202 2310 Inj Ganciclovir

600mg

Each vial contains:

Ganciclovir 600 mgBox of 10 Vial 2 Years --- Yes --- as may be required 1000

203 2311

Sodium Chloride Inj

1000ml

(For IV infusion)

IPcontains:

Sodium chloride IP 0.9% w/v

1000ml FFS Bottle

packed



Form Fill & Seal

Technology



204 2312 Cyclophosphamide

Injection 1 Gm IP

Each Vial contains:

Cyclophosphamide 1 gm



205 2313

Fluro-Uracil

Injection

500mg/10ml

IPEach Amp contains:

Fluro-Uracil IP 500mg

10 ml Amp Individually

Packed2 Years 500 Yes 50 Box 5000 Amp 1000

206 2314

Inj Balance Salt

Solution

(Glass Bottle) 500 ml

IP

Contains:

Sodium chloride IP 0.49 % w/v,

Pottasium Chloride IP 0.075 % w/v,

Calcium chloride IP 0.048% w/v,

Magnesium chloride, WFI IP q.s.

500 ml glass Bottle

Individually packed2 Years --- Yes

500

Bottleas may be required 1000

207 3002

Albendazole

Suspension

200 mg/5 ml (10 ml

Bottle)

---Each 5 ml contains:

Albendazole IP 200 mg.

10 ml Bottle Individually

pack($)2 Years 5000 Yes

300


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

208 3013

HbSAg-Rapid Test Kit for

detection of Hepatitis B

surface Antigen (HbSAg)

in Plasma/Serum

--- Composition/Specifications:

As per Annexure

ONE TEST UNIT

(Kit containing upto 100

Test)

2 Years --- Yes --- 1165000 Test 213200

209 3015

Betamethasone Valerate

CreamIP/BP

/

EP/

USP

Contains: Betamethasone Valerate

BP/EP/USP/IP eq.to 0.05% of

Betamethasonein a suitable cream

base

15 gm Tube Individually

packed($)2 Years 10000 Yes 500 Tube 5734000 Tube 903000

210 3024

Chloroquine

Phosphate

Syrup 100 mg/10ml

IP

Each 5 ml contains:

Chloroquine Phosphate IP 80 mg

eq.to Chloroquine 50 mg.

60 ml Plastic Bottle of

PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 5000 Yes100


211 3026

Cholecalciferol

Granules

(Vitamin D3)

---Each Alluminium Sachet contains:

Cholecalciferol IP 60,000 I.U.

One Alluminium sachet

hermetically sealed (light

resistant) in which the air

has

been replaced by

nitrogen/

inertgas. ($)


Sachet2228000 Sachet 198000

212 3028 Clotrimazole Cream 1% IP Contains: Clotrimazole IP 1% w/w15gm Tube Individually


213 3029

Compound Benzoic

Acid

Ointment

(Whitefield's oint.)

IP

Contains: Benzoic acid IP 6% w/w

Salicylic Acid IP 3% w/w

Emulsifying base q.s.

30gm Tube Individually


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

214 3030

Vitamin A Solution

Conc.

100000 IU/1ml

IP

Each ml contians:

Vitamin A IP 100000 IU

Vitamin A Solution is

yellow/brownish

yellow oily liquid containing suitable

agents such as antioxidants.

The quality of Vitamin A, vegetable

oil

and stabilizing agent should confirm

to

the requirement of IP

100ml Amber Colored

Bottle individually

packed

with 2ml spoon with

marking at 1ml


215 3033

Dextromethorphan

Syrup

13.5 mg/ 5 ml

IP

Each 5 ml contains:

Dextromethorphan

Hydrobromide IP 13.5 mg


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 5000 Yes100


216 3037

Dicyclomine HCL

Oral

Solution 10 mg/5ml

IPEach 5 ml contains:

Dicyclomine Hydrochloride IP10 mg


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)



217 3065Halothane Liquid

250ml Bottle--- ---

250 ml Amber Coloured

tightly closed Bottle

Individually packed.


218 3068

Hydrogen Peroxide

Solution 200 ml

Bottle

IPHydrogen Peroxide

Solution 6% (20 volume)


Plastic Bottle.($)2 Years 2000 Yes 50 Bottle 315000 Bottle 74800

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

219 3070Ibuprofen Suspension

100 mg/5 ml

IP/BP

/

USP

Each 5 ml contains:

Ibuprofen IP/BP/USP 100mg.


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 5000 Yes100


220 3073Isoflurane Liquid

(100 ml)

BP/

EP/

USP

---


tightly closed glass Bottle

Individually packed


221 3088Paracetamol Syrup

125 mg/5 mlIP

Each 5 ml contains:

Paracetamol IP 125 mg.


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 5000 Yes100


222 3090Petroleum Jelly

(White)IP --- 1 Kg. Metal Tin 2 Years 500 Yes 15 Tin 65000 Tin 296900

223 3100

Povidone Iodine

Solution

5% 1 Litre Jar

IPContains: Povidone Iodine IP 5% w/v

(Available Iodine (I) 0.5%)

1 Litre "A" type Plastic

Jar/Pet Bottle2 Years 1000 Yes 16 Bottle 174000 Bottle 355000

224 3105

Salbutamol Syrup

2 mg/5 ml

100ml Bottle

IP

Each 5 ml contains:

Salbutamol Sulphate IP

eq. to Salbutamol 2mg.

100ml Plastic Bottle of

PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 3000 Yes100


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

225 3106Sevoflurane Liquid

with quick fill adaptor--- ---

250 ml Bottle

Individually

packed


226 3107

Silver Sulphadiazine

Cream 1%

500 gm Jar

BP/

EP/

USP

Contains: Silver Sulphadiazine USP

1%

500 gm Amber colour

wide

mouth Jar wrapped in

black

paper.

2 Years 1000 Yes 20 Jar 150000 Jar 616500

227 3109Sodium Hypochlorite

Solution 5 Liter Jar

BP/

EP/

USP

Contains: Not less than 4% & not

more

than 6% by weight of Naclo.

5 Liter tightly closed light

resistant "A" type plastic

container.

2 Years 1000 Yes 4 Jar as may be required 1000

228 3111

Reagent Strips for

Estimation of

Albumin &

Glucose in Urine

---

Opaque, Plastic Reagent strips with

two

filter papers affixed to them,

one is impregnated with indicator &

buffer for the estimation of Albumin

Bottle of 50 Strips

Individually packed. ($$)2 Years 2000 Yes

100

Bottleas may be required 1000

{Protein} in Urine & another with

enzymes & chonogen for quantitative

estimation of Glucose in Urine.

Yes

229 3114 Timolol Maleate

Eye Drops 0.25% IP

Contains: Timolol Maleate IP

eq.to Timolol 0.25%

5ml FFS Vial (plastic

container) with screw cap

spike ($)

2 Years 500 Yes 500 Vial 89000 Vial 13400

230 3117

Trimethoprim &

Sulphamethoxazole

Oral Suspension

IP

Each 5 ml contains:

Trimethoprim IP 40 mg

Sulphamethoxazole IP 200 mg


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 5000 Yes100


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

231 3131 Calamine Lotion IP

Contains: Calamine IP 150gm, Zinc

Oxide IP 50gm, Bentonite IP 30gm,

Sodium Citrate IP 5gm, Liquified

Phenol IP 5ml, Glycerin IP 50ml,

Purified Water to produce 1000ml

30ml Plastic Bottle ($$) 2 Years 5000 Yes200


232 3138

HCV Elisa Test Kit

Hepatitis C virus antibody

detection 3rd Generation

test (ELISA)

--- Composition/Specification:

As per Annexure

ONE TEST UNIT


Tests)

2 Years --- Yes --- 611000 Test 178700

233 3139

HCV Rapid Test Kit

Hepatitis C Virus 3rd

Generation Test (Rapid) ---

Composition/Specification:

As per Annexure

ONE TEST UNIT


Test)

2 Years --- Yes --- 308000 Test 202700

234 3142

Povidone Iodine

Ointment

5% (20gm Tube)

BP/

EP/

USP

Contains:Povidone Iodine IP 5% w/w

(Available iodine 10% of

thestrength) Water soluble

base...Q.S.



235 3143

Pregnancy Test Kit

(HCG Dipstick) (50

Test)


As per Annexure

ONE TEST UNIT


Tests)

2 Years --- Yes --- 6782000 Test 333400

236 3157

Serum VDRL Test

Kit

(RPR Flocculation

Test)


As per Annexure

ONE TEST UNIT


Test)

2 Years --- Yes --- 2723000 Test 66300

237 3158

Serum Widal Test Kit

(Rapid Slide Test)

(4x5ml)


As per Annexure

ONE TEST UNIT

(Kit of 4x5ml)2 Years --- Yes --- 490000 Test 20400

238 3159

Silver Sulphadiazine

Cream

1% (20gm tube)

BP/

EP/

USP

Contains: Silver Sulphadiazine

BP/EP/USP 1% w/w



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

239 3162

Azithromycin Oral

Suspension

200mg/5ml

IPEach 5 ml contains:

Azithromycin IP 200mg15ml Bottle ($$) 2 Years 10000 Yes

200


240 3168

Diazepam Rectal

Solution

2mg/ml

BP

Each ml contains: Diazepam IP 2mg,

Benzyl Alcohol IP 1.5% w/v,

Sodium Benzoate IP 1% w/v

Unit of 2.5ml vial with

applicator Individually

packed($)

2 Years 1000 Yes 500 Unit 3000 Vial 1000

241 3175

Compound Benzoin

Tincture 500 ml

Bottle

IP

Contains:

Benzoin IP 100gm(in moderately

coarse

powder); Prepared Storax IP 75mg;

Tolu Balsam IP 25gm; Aloes IP

20gm

(in moderately coarse powder);

Ethanol

(90%) IP sufficient to produce

1000ml

500ml Amber Coloured

Bottle2 Years 2000 Yes

20


242 3183Clobetasol Propionate

CreamIP

Contains:

Clobetasol Propionate IP 0.05%

W/W

15 gm Tube Individually


243 3200

Levocetirizine

Dihydrochloride

Syrup

30 ml Bottle

---

Each 5ml contains:

Levocetirizine Dihydrochloride IP

2.5mg

Flavoured Syrup base….. q.s.


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

244 3202Permethrin Cream 5%

30gm Tube---

Each gm contains: Permethrin 50mg.

Preservative formaldehyde solution

BP 1mg. Cream base q.s.


Packed ($)2 Years 5000 Yes 500 Tube 258000 Tube 82800

245 3203Lactulose Solution

100 ml Bottle

IP/BP

/

USP/

EUP

Each 5ml contains: Lactulose

Concentrate IP/BP/USP/EUP eq.to

lactulose 3.35 gm, Aqueous base q.s.

100ml Bottle Individually

Packed ($$)2 Years 2000 Yes

100


246 3207Cephalexin Syrup

125 mg/5 mlIP

Each 30ml Bottle contains:

Anhydrous cephalexin IP 750mg.


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)

2 Years 5000 Yes100


247 3209Glycerine 100 ml

BottleIP

Each Bottle contains: Glycerine IP

100ml 100ml PET Bottle ($$) 2 Years 5000 Yes

100


248 3211Magnesium Sulphate

Powde--- Magnesium Sulphate IP 500gm. Box of 500gm 2 Years --- Yes 100 Box 11000 Box 5900

249 3214

Petroleum Jelly

(White)

30 gm Tube

---Each Tube contains:

Petroleum Jelly (White) 30gm.


Packed ($)2 Years 5000 Yes 300 Tube 1395000 Tube 367900

250 3216Zinc Gluconate Syrup

20 mg/ml---

Each ml contains:

Zinc Gluconate 20mg.


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)



Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

251 3224

Cyclopentolate Eye

Drop

5ml

USP/

BP/

EUP

Each ml contains:

Cyclopentolate HCL

USP/BP/EUP 1% w/v

5ml FFS Vial (Plastic


spike ($)


252 3225

Lignocaine HCL Jelly

5%

30gm Tube

USP/

BP/

EUP

Contains:

Lignocaine Hydrochloride 5% w/w


Packed2 Years 5000 Yes

500

Tube 235000 Tube 211500

253 3227

Moxifloxacine Eye

Drop

5ml

IPContains:

Moxifloxacin HCL IP 0.5% w/v



spike ($)


254 3230

Prednisolone Acetate

Eye

Drop 0.1%, 5ml

USP/

BP/

EUP

Contains:

Prednisolone Acetate

USP/BP/EUP/IP 0.1% w/v



spike ($)


255 3231

Tobramycine Eye

Drop

0.3% w/v, 10ml

USP/

BP/

EUP

Contians:

Tobramycin USP/BP/EUP 0.3% w/v



spike ($)


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

256 3232Iron Folic Acid

(IFA) Syrup---

1 ml of Iron Folic Acid (IFA) Syrup

should contains 20mg elementary

Iron

and 100 mcg folic acid.

Each Bottle should be of

100ml & it should have

on

autodispenser so that only

1ml of syrup will be

dispensed

at a time.(IFA

information

leaflet as per annexure in

the

mono-cartoon of IFA

Syrup)

2 Years 5000 Yes100


257 3234

Dianoprostone Gel

3%

3gm

---

Each Pre-filled Syringe contains:

Dinoprostone BP 0.5 mg in a suitable

base.

3 gm Pre-filled syringe 2 Years 2000 Yes

500

Pre-

fiilled

Syringe

105000 Pre-fiilled

Syringe537400

258 3236

Clotrimazole with

Beclomethasone EAR

Drops 1% Any

Each ml contains: Clotrimazole IP

1%

with Beclomethasone Dipropionate

IP

0.025% Drops

5ml Vial (Plastic

container)

with screw cap spike ($)


259 3237

Neomycin,

Hydrocortisone

& Polymixin B Ear

Drops

---

Each ml contains:

Neomycin Sulphate eq.to 3400 IU

Neomycin base, Polymixin B 10000

IU,

Hydrocortisone 5 mg



spike ($)


260 3238

Brimonidine Tartrate

and

Timolol Eye Drops

0.15% + 0.5%

---

Each ml contains:

Brimonidine Tartrate 0.15% w/v &

Timolol Maleate 0.5% w/v



spike ($)


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

261 3240

Tobramycin and

Dexamethasone

Ophthalmic

Suspension

0.3%+0.1%

---

Each ml contains:

Dexamethasone 0.1% w/v &

Tobramycin 0.3% w/v



spike ($)


262 3244

Hydroxypropyl

Methylcellulose 2%. Each ml contains:

Hydroxypropyl Methylcellulose

Soln 20 mg



spike ($)


263 3245

Neomycin Sulphate,

Polymyxine B

Sulphate,

Bacitracon Zinc

Powder

(10gm)

---

Each gram contains:

Polymyxin B Sulphate 5000 Units,

Bacitracin Zinc IP 400 Units,

Neomycin Sulphate IP eq to

Neomycin

3400 Units

10 gm Powder

Individually

Packed.($)

2 Years 5000 Yes 500 No. 864000 No. 421200

264 3246

Artemether &

Lumefantrine

Syrup (Pediatric)

(15ml Bottle)

---

Each 5ml contains:

Artemether IP 40 mg &

Lumefantrine 240 mg


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($)

2 Years 3000 Yes100


265 3315

Syrup Lopinavir (80

mg/ml)

+ Ritonavir

(20mg/ml)

(160ml Bottle)

---

Each ml contains:

Lopinavir 80 mg &

Ritonavir 20 mg


PET/

PETG or

Polypropylene(PP)

with Pharmacopoeial

quality

($$)


266 4004Adhesive Zinc Tape

5cmx10mtrUSP

Each Roll of size:

5cmx10mtrCylinder of 6 Rolls 2 Years 1000 NA

20

Cylinder409000 Roll 474000

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

267 4005Adhesive Zinc Tape

7.5cmx10mtrUSP

Each Roll of size:

7.5cmx10mtrCylinder of 4 Rolls 2 Years 1000 NA

20

Cylinder199000 Roll 358200

268 4007Blood Administration

Set (ETO)---

As per IS No: 9824-1981 and as

amended from time to time Sterilised

by ETO method with airway

One Set Individually

Packed

(Such 25 Set should be

packed in polythene bag)

2 Years 5000 NA 500 Set 503000 Set 82200

269 4009Crepe Bandage Pack

(10cmx4mtr)BP Roll of 10cmx4mtr

One Roll Individually

Packed

(Such 10 Roll should be

packed in a box/ poly

bag)

2 Years 3000 NA 80 Roll 396000 Roll 354000

270 4010Crepe Bandage Pack

(6cmx4mtr)BP Roll of 6cmx4mtr


Packed



bag)


271 4011

Disposable

Hypodermic

Needle Size: 22x1"

---

Sterile Hypodermic Needles for

single

use,as per IS:10654:2002 as amended

from time to time.

Box of 100 Needle

Individually

Blister Strip Packed with

medical grade paper

2 Years 20000 NA 60 Box 20357000 Needle 265700

272 4013

Disposable

Hypodermic

Needle Size: 23x1"

---


single


from time to time.

Box of 100 Needle

Individually


medical grade paper


273 4015

Disposable

Hypodermic

Needle Size: 24x1"

---


single


from time to time.

Box of 100 Needle

Individually


medical grade paper


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

274 4017Infusion Set

(E.T.O.Sterilised)---

As per IS

No:12655,Sterile,Disposable,

Nontoxic, Nonpyrogenic,sterilised by

ETO radiation method,With

bulblatex;

molded dripping chamber &

Siliconized

good quality needle Size: 21Gx1.5";

Daimeter (I.D.) of tube 2.7 to

3.00mm;

Length of Tube: 150 cms.

One Set Individually

Packed

(Such 25 Set should be

packed in polythene bag)

2 Years 10000 NA 500 Set 21041000 Set 2506000

275 4019

Disposable Syringe

10 ml

(Without Needle)

---

Natural,Vergin Plastic Syringes as

per

IS 10258:2002 as amended

from time to time

Box of 50 Syringe

Individually

Blister Strip packed with

medical grade paper

2 Years 10000 NA 20 Box 22788000 Syringe 1292100

276 4020

Disposable Syringe 2

ml

(Without Needle)

---

Sterile Single Use Syringes as per

IS:10258:2002 as amended

from time to time

Box of 100 Syringe

Individually


medical grade paper


277 4021

Disposable Syringe 5

ml

(Without Needle)

---


IS:10258:2002 as amended

from time to time

Box of 100 Syringe

Individually


medical grade paper


278 4022

Plaster Of Paris

Bandage

(10cm x 2.7mtr)

BP Roll of size: 10cm x 2.7mtr


Packed



bag)


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

279 4023

Plaster Of Paris

Bandage

(15cm x 2.7mtr)

BP Roll of size: 15cm x 2.7mtr


Packed



bag)


280 4024Rolled Bandage

(5mtr x 5cm)ISI

Handloom Cotton Bandage cloth

Non-sterilized, IS:863:1988 as

amended from time to time

One Roll of 5mtrx5cm

(Such 12 Rolls should be

packed in a polybag)

2 Years 2000 NA 200 Pkt 6796000 Roll 703200

281 4028

Ab.Surg.Sut.Catgut

Plain

2-0 w/o needle

USP

Length: 152 cms. Non-boilable

catgut

Plain Diameter: 2-0

Pkt. of 12 Foils 2 Years 500 Yes 100 Box 43000 Packet 23200

282 4035Ab.Surg.Sut.Catgut

Chromic 1 w/o needle

USP/

BP/

EUP


catgut

Chromic Diameter: 1


283 4036Ab.Surg.Sut.Catgut

Chromic 2 w/o needleUSP


catgut

Chromic Diameter: 2


284 4038

Ab.Surg.Sut.Catgut

Chromic 2-0 w/o

needle

USP


catgut

Chromic Diameter: 2-0


285 4045

Ab.Sur.Sut.Chromic

2-0 with

1/2Cir.RB30mm

USP/

BP/

EUP

Length: 76 cms. Non-boilable catgut

Chromic 1/2 circle round bodied

30mm

Diameter: 2-0


286 4047

Ab.Sur.Sut.Chromic

3-0 with

1/2Cir.RB20mm

USP/

BP/

EUP

Length: 76 cms. Non-boilable catgut

Chromic 1/2 circle round bodied

20mm

Diameter: 3-0


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

287 4063

Ab.Sur.Sut.Polygly.

3-0

with1/2Cir.RB17mm

USP/

BP/

EUP

Length: 75 cms. Polyglycolic acid

suture

1/2 circle round bodied 17mm.

Diameter: 3-0


288 4090

Non-abs.BB.Silk

sur.on

Reel 1 (25mtr)

USP Length: 25 mtrs Diameter: 1 Box of 6 Reel 2 Years 250 Yes 50 Box 31000 Box 41900

289 4120

Non-

ab.Monofi.Polyamid

3-0 3/8cir cut16mm

USP

Length: 70 cms. Monofilament

Polyamide 3/8 circle cutting 16 mm

Diameter: 3-0


290 4121

Non-

ab.Monofi.Polyamid

4-0 3/8cir cut16mm

USP

Length: 70 cms. Monofilament

Polyamide 3/8 circle cutting 16 mm

Diameter: 4-0


291 4179Absorbent Cotton

Wool 400gmIP ---

400 gm Packet, packed in

brown paper2 Years 1500 NA

Bale of

50 Pkt826000 Single Pkt 1677000

292 4182Disposable Needle

Size: 26x0.5"---


Single

Use as per IS:10654:2002 as

amended

from time to time

Box of 100 Needle

Individually

Blister packed in medical

grade

paper


293 4184

Insulin Syringe 1 ml

with

graduation upto 100

units

with prefixed 28G x

1/2

---

Sterile Single Use Syringes for

Insulin as

per IS:12227:2002 as amended from

time to time

Ribbon Pack Insulin

Syringe

with needle (Such 100

No.

should pack in a Box)


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

294 4187

I.V. Cannula with

Injection

Valve Size: 16

G(E.T.O.Radiation

Method)

---

It is provided with Inj. site, & one

way

retreating valve to facilitate extra

medication & to prevent back flow.

colour coded valve cap for size

identification as per international std.

ETO Sterile & Non-pyrogenic

*:PTFE/

FEP/PU, Catheter. Silliconized

Needle

One Unit Packed

Individually

Blister strips with medical

grade paper.(Supply in a

box

of 4x25 units in a poly

bag.)

2 Years 10000 NA1000

Units38000 Unit 6700

295 4188

I.V. Cannula with

Injection

(E.T.O.Radiation

Method)

Valve Size: 18 G

---


way






*:PTFE/


Needle

One Unit Packed

Individually



box


bag.)

2 Years 10000 NA1000

Units914000 Unit 126100

296 4189

I.V. Cannula with

Injection

(E.T.O.Radiation

Method)

Valve Size: 20 G

---


way






*:PTFE/


Needle

One Unit Packed

Individually



box


bag.)

2 Years 10000 NA1000

Units2768000 383600

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

297 4190

I.V. Cannula with

Injection

(E.T.O.Radiation

Method)

Valve Size: 22 G

---


way






*:PTFE/


Needle

One Unit Packed

Individually



box


bag.)

2 Years 10000 NA1000

Units3273000 Unit 448700

298 4191

I.V. Cannula with

Injection

(E.T.O.Radiation

Method)

Valve Size: 24 G

---


way






*:PTFE/


Needle

One Unit Packed

Individually



box


bag.)

2 Years 10000 NA1000

Units2147000 Unit 345200

299 4198

Elastic Adhesive

Bandage

(E.T.O.Radiation

Method)

Size: 10cm X 2.70mtr

BP

Roll of Size width 10cm x length

2.7mtr

(After Streched length 4/6 mtrs)


Packed

in metal container with

lid


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

300 4227

Foley's Catheter 8 FR

(3 to 5 CC Balloon)

(Paed)

Any

Smooth, Siliconized Rubber Latex

Catheter having self-retaining

balloon

with stiff & adequate thickness of tip.

Size and arrangement of four

drainage

eyes,valves,adepter nozzal &

capallary

tube should comply with its usage &

international std.

One Unit Packed

Individually

and must be sterilised by

Gamma Radiation/ E.T.O.

Radiation Method. (Such

100 Units should packed

in a

cardboard box)

2 Years 3000 NA 500 Nos. 42000 Unit 38700

301 4228

Foley's Catheter 10

FR

(3 to 5 CC Balloon)

(Paed)

Any



balloon



drainage


capallary


international std.

One Unit Packed

Individually





in a

cardboard box)

2 Years 3000 NA 500 Nos. 32000 Unit 29500

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

302 4229

Foley's Catheter

for Adult use: 12 FR

(30 to 50CC Balloon)

(2 Way)

Any



balloon



drainage


capallary


international std.

One Unit Packed

Individually





in a

cardboard box)

2 Years 3000 NA 500 Nos. 70000 Unit 36800

303 4230

Foley's Catheter



(2 Way)

Any



balloon



drainage


capallary


international std.

One Unit Packed

Individually





in a

cardboard box)

2 Years 3000 NA 500 Nos. 239000 Unit 125500

Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

304 4231

Foley's Catheter



(2 Way)

Any



balloon



drainage


capallary


international std.

One Unit Packed

Individually





in a

cardboard box)

2 Years 3000 NA 500 Nos. 425000 Unit 223100

305 4232

Foley's Catheter



(2 Way)

Any



balloon



drainage


capallary


international std.

One Unit Packed

Individually





in a

cardboard box)

2 Years 3000 NA 500 Nos. 151000 Unit 79300

306 4269Disposable

Syringe 20 ml---


IS:10258:2002 as amended from

time to time

Box of 50 Syringe

Individually

Blister strip packed with

medical grade paper


307 4270Disposable

Syringe 50 ml---


IS:10258:2002 as amended from

time to time

Box of 25 Syringe

Individually

Blister strip packed with

medical grade paper


Sr.

No.

Item


Shelf Life

(Minimum)

Min.

Batch

Size

WHO

GMP

Packing

per

carton

2 year

Approx.

Requirement

EMD

(Rs.)

1 2 3 4 5 6 7 8 9 10 11 12

T.E.No.GMSCL/D-629/RC/2018-2019

308 4275Disposable Spinal

Needle (Size: 22G)Any

Sterile Disposable Spinal Needle of

size

22G x 3 1/2" Individually Packed,as

per

IS standard as amended from time to

time.

Box of 50 Needle

Individually

Ribbon packed

2 Years 1000 NA1000

Needle12000 Needle 8200

309 4278Disposable Spinal

Needle (Size: 23G)Any

Sterile Disposable Spinal Needle of

size

23G x 3 1/2" Individually Packed,as

per

IS standard as amended from time to

time.

Box of 50 Needle

Individually

Ribbon packed

2 Years 1000 NA1000

Needle233000 Needle 152000

310 4305

Micropore

Adhesive

Paper Tape

Each Roll of size: 1.25cms x 9.1 mtr Box of 12 Roll. 2 Years --- NA --- 435000 Roll 71800

9. Marking : Printing/marking on Kit will be as per Drug & Cosmetics Rules.

10. WHOGMP -Yes-compulsory WHOGMP Required. & NA-Not Applicalbe Column No 9.i.e.Items excluded from WHOGMP Certification.

2. For Tablet-Capsules items ($) means such 10 box should be packed in polybag /cellophen.

3. Rate contract will be/may be awarded on the basis of available information regarding approximate requirement.

4. EMD is calculated on the basis of available information of This year purchase Amount for Indent list Items/NPPA/Previous RC rate.

5. Any deviation in Packing will be mentioned in Remark Column but Rate should be quoted very carefully as per packing unit column No 6.

6. FFS vial means plastic Vial manufactured under Form Fill & Seal technology in aseptic enviornment.

N.B.

1. Minimum batchsize means the quantity stated in column No.8 or the quantity in requisition order issued rate contract whichever is less.

8. For Miscelleneous items ((Liquid preparations {Oral/External},Ointments, Eye/Ear preparations, ($) means such 10 units/tubes/vials/sachets/pkts.

7. For Miscelleneous items ((Liquid preparations {Oral/External},Ointments, Eye/Ear preparations, ($) means such 10 units/tubes/vials/sachets/pkts. should be packed in a poly

bag/cellophen/box and ($$) Means such 10 Bottles should be packed in a Box.In case of Glass Bottle Divider must be used.